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ABSTRACT 
To determine the placental tropism, abortigenicity, immunogenicity and effect on 
TNF-a levels, pregnant cattle were vaccinated IV (n=10) or SC (n=5) with the vaccine 
Brucella abortus strain RB51 (SRB51), SC with strain 19 (SI9) (n=5), or saline (n=2) at 6 
months gestation. Eight of ten IV vaccinated heifers developed placentitis and fetal 
infection. Strain RB51 was cultured from all tissues in which lesions were seen. No lesions 
were seen in SC vaccinated cattle and SRB51 was isolated from 2/5 superficial cervical 
lymph nodes in the area draining the site of SC vaccination. One premature calf bom to an 
rv vaccinated heifer had mild interstitial pneumonia and disseminated SRB51 infection. No 
lesions were seen in other calves from IV vaccinated heifers, heifers vaccinated SC with 
SRB51 or SI 9, and neither SRB51 nor S19 could be recovered from calves of SC vaccinated 
cattle. Maternal PBMC from SRB51 vaccinates and S19 vaccinates showed proliferative 
responses to both y-irradiated SRB51 and S19 which were greater than controls. Strain RB51 
vaccinates did not develop antibodies detected by the standard tube agglutination test, but did 
develop antibodies to SRB51 that reacted in a dot ELISA test with irradiated SRB51. 
Radioimmunoassay for bovine plasma TNF- a revealed insignificant differences (P>0.05) 
between SRB51 vaccinates, S19 vaccinates and controls. Similarly, TNF-a levels in 
amniotic or allantoic fluids from vaccinated cattle were not different from placental fluids of 
controls (P>0.05). Immunohistochemistry for TNF-a revealed increased immunoreactivity 
within trophoblastic epithelial cells which was most extensive in FV vaccinated cattle with 
vaccine- induced placentitis. These results indicate that SRB51 is less abortifacient than 
previously published reports vvith S19; however, SRB51 can infect the bovine placenta and 
fetus, can induce placentitis, and in some cases, lead to preterm expulsion of the fetus. 
Undesirable effects of SRB51 are dependent on dose and route of administration as SC 
vaccination with a lower dose does not result in placental or fetal infection. 
I 
CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Brucellosis is an economically important abortifacient disease of cattle. Since 1940, 
the United States has been actively engaged in a brucellosis eradication effort. A cornerstone 
of this effort has been the vaccination of young female calves with the live brucellosis 
vaccine Brucella abortus strain 19 (SI9). Strain 19 has been effective in decreasing the 
incidence of bovine brucellosis; consequently, the goal of the United States Department of 
Agriculture (USD A) is the eradication of bovine brucellosis from the United States by the 
end of 1998. Although effective in the prevention of brucellosis, S19 is not without 
limitations. An obstacle to the eradication effort is the inability to serologically distinguish 
S19 vaccinates from naturally infected cattle. Additionally, infrequent but problematic 
sequelae of SI9 vaccination include abortion in pregnant cattle, arthritis,^^ anaphylaxis,^^ 
"yi "J gg 
and persistent infection. 
In April, 1996, for the first time in half a century a new brucellosis vaccine was 
approved for use in cattle. The vaccine. Brucella abortus strain RB51, is as effective as S19 
in the prevention of brucellosis," but allows the serologic distinction of vaccinates from 
naturally infected animals.^ ^ 
When brucellosis infected herds have been detected, the USDA has implemented the 
practice of whole herd vaccination, where all female cattle, regardless of age or pregnancy 
status are vaccinated. In such situations, safety of SRB51 in pregnant cattle would be 
necessary to avoid widespread abortion. The studies presented in this dissertation were 
2 
designed to determine; 1) the tropism of SRB51 for the bovine placenta, 2) the ability of 
SRB51 to colonize the placenta, induce placentitis and cause abortion, 3) the 
immimogenicity of SRB51 vaccination in pregnant cattle, measuring both humoral and cell 
mediated responses, and 4) the effect of SRB51 vaccination on levels of the potent 
proinflammatory cytokine, TNF-a, in plasma and placental tissues. 
Literature Review 
Historical Background 
Human brucellosis was known possibly as early as the time of Hipocrates who 
described the symptoms of prolonged, intermittent fever; however, the earliest accurate 
description of the disease in man was made in 1861 when Marston designated it as 
Mediterranean fever and described the disease as " a preliminary stage of dyspespsia, 
anorexia, nausea, headache, feeling of weakness, lassitude, and inaptitude of exertion, mental 
or physical; chills, muscular pains, and lastly a fever having a long course 3 to 5 or 10 weeks, 
marked by irregular exacerbations and remissions, great derangement of the assimilative 
organs, tenderness in the epigastric region, and splenic enlargement. It is prone to relapses, 
has a protracted convalescence, and is frequently marked by rheumatism." The name 
38 
"imdulant fever" was given to the disease in humans by Hughes in 1897. In 1887 Colonel 
David Bruce discovered a microorganism isolated from the spleen of fatal cases of Malta 
fever, also known as Mediterranean fever or undulant fever, in soldiers on the island of 
Malta. The causative organism, now known as Brucella melitensis, was named 
J 
38 Streptococcus melitensis by Hughes in 1892 and Micrococcus melitensis in 1893 by Bruce. 
Further confirmation of Bruce's conclusions were made in 1897 when it was shown that the 
organism that Bruce identified was agglutinated by sera from afflicted patients.'" The 
association of the disease in man with that seen in goats was recognized in 1905 when local 
goats on the island of Malta, which were going to be used as experimental animals, were 
found to have preexposure agglutinating antibodies to the organism. Subsequent culture of 
milk from the goats yielded the causative organism of Malta fever.'"* 
As early as 1864 epizootics of abortion were known to occur in regions of Louisiana 
and the Mississippi River. In 1864 in Cattle and their Diseases, Richard Jennings describes 
epizootics of abortion which he hypothesized were of a sympathetic or empathetic nature; 
that is, when one cow observed another cow aborting she would also abort in a few days or a 
few weeks. As erroneous as his etiologic diagnosis was, his recommended treatment of 
isolation of cows during calving so other cows could not observe an abortion, did help in 
controlling the disease. In 1862, Nocard, a French bacteriologist, first recognized the 
presence of bacteria between the fetal membranes and the wall of the uterus of a pregnant 
cow following abortion. Similarly, in 1897, Bang, a Danish veterinarian, assisted by Stribolt, 
noted a thick yellow exudate between fetal membranes and the uterus from an abortion. 
From this exudate they isolated a microorganism which when injected into pregnant cows 
caused abortion. The organism was reisolated from the abortion materials and injected into 
pregnant cows, reproducing abortion. Bang and colleagues were also able to produce 
abortion in pregnant sheep injected with the organism. Bang designated the organism. 
4 
Bacillus abortus and the disease came to be known as Bang's disease.^' The diseases of 
Malta fever in man and contagious abortion in cattle were studied independently and no 
connection between the two diseases was made until 1918. Evans made this connection by 
demonstrating the close morphological, cultural and serological relationship between the two 
bacteria causing the disease in man and sheep, B. melitensis and B. abortus, respectively, 
28 
which are now known to be very closely related. 
In Rhodesia, Duncan was the first to recognize and report brucellosis in man due to B. 
abortus}^ The first case of brucellosis in America that was reported as being caused by other 
than B. melitensis was recognized in 1924;^° however, it was later found to be caused by B. 
suis rather than B. abortus. 
Description of the genus. Brucella 
Brucella abortus is of the Order Eubacteriales, Family Brucellaceae. The genus 
Brucella is unrelated to other pathogens but is closely related to the agrobacterium-
rhizobium complex. Seven species of Brucella exist with preferential host relationships: B. 
abortus (cattle), B. melitensis (goats), B. suis (swine), B. neotomae (desert wood rat), B. canis 
(dogs), B. ovis (sheep) and a poorly characterized Brucella sp. isolated from dolphins."^ All 
88 Brucella are closely related and share greater than 90% DNA homology. Some authors have 
suggested that only one species be recognized. Brucella melitensis, and that other specific 
epithets previously used as species names be used to designate biovars (e.g. Brucella 
88 
melitensis biovar Aborms). 
5 
Brucella organisms are Gram-negative, cocco-bacilli, arranged singly, or occasionally 
in pairs or small groups. True capsules are not detected and Brucella do not form spores and 
are nonmotile. Brucella are aerobic and many strains require supplemental CO2 for optimal 
growth. Growth can be stimulated by the addition of 5 to 10% normal serum. Colonies 
generally become visible after 3 days incubation; however, growth may require up to 10 
days in some cases. Brucella colonies after 3-5 days incubation are round, 1-2 mm in 
diameter with smooth margins, translucent and a pale honey color when viewed from through 
a transparent medium using a low power microscope and obliquely transmitted light. 
Viewed from above, colonies are convex and pearly white.^ 
Description of B. abortus strain RB51 
Brucella abortus strain RB51 (SRB51) is a rifampin-resistant strain of B. abortus 
derived by repeated passage of strain 2308 on trypticase soy (TS) broth supplemented with 
varying concentrations of rifampin.'^ SRB51 is highly deficient in the 0-side chain 
component of LPS when compared to the parental 2308, but may contain small amounts of 
the perosamine homopolymer which is the 0-chain component of B. abortusRough 
morphology is characterized by absorption of crystal violet, autoagglutination and lack of the 
0-chain component in LPS extracted from SRB51 on SDS - PAGE gels. Furthermore, 
Western blot analysis with the monoclonal antibody BRU 38, specific for the perosamine 
homopolymer 0-chain of smooth Brucella LPS indicates that SRB51 is highly deficient in 
the 0-chain compared to 2308.^' Biochemically, SRB51 resembles 2308 in the ability to 
6 
metabolize erythritol/^ This ability is linked to the presence of the eri gene which is present 
in both SRB51 and 2308, but absent in B. abortus strain 19 (SI9). 
B. abortus strain RB51 as a vaccine 
Vaccination v^th SRB51 is protective in mice and cattle which are challenged after 
vaccination with virulent B. abortus Cattle vaccinated with SRB51 remain serologically 
negative when tested by conventional brucellosis surveillance tests including tube 
agglutination, particle concentration fluorescence immunoassay (PCFA), card test and 
81 
complement fixation (CF). These tests measure antibody responses to the LPS 0-side 
chain of B. abortus and, therefore, do not measure anti-SRB51 antibodies. 
SRB51 is cleared more rapidly than S19 or S2308 in both murine spleens and bovine 
lymph nodes.In mouse spleens, SRB51 was not cultured beyond 4 weeks after 
infection while S19 and S2308 were present at 10 and 20 weeks after infection, 
respectively.^^ In bovine lymph nodes, SRB51 was not recovered from lymph node biopsy 
specimens at 6 weeks after vaccination while S19 and S2308 were cultured at 8 weeks after 
vaccination.'' 
Strain 19 induced abortion 
The eradication of bovine brucellosis has centered on the use of Brucella abortus 
strain 19 (SI9), an attenuated, live vaccine introduced into the federal brucellosis program in 
1940. Although S19 has been an effective tool in the control of bovine brucellosis for over 
7 
50 years it has significant limitations. These limitations include not only the production of 
antibodies indistinguishable from those resulting from natural infections, but also the ability 
32.61 8 58 to induce abortion in pregnant cattle. " ' As early as 1937 it was noted that experimental 
subcutaneous injection in pregnant cattle of a dose of 2 x lO" S19 organisms may produce 
typical clinical signs and lesions of brucellosis with the discharge of large numbers of the 
organisms in uterine material at the time of parturition.^^ Cattle in which S19 vaccination 
induced weak or dead calves were in late gestation when vaccinated. However, one cow 
vaccinated at 4 months gestational age and challenged with a virulent strain 32 days later 
gave birth to a weak calf with S19 being isolated from placental and fetal tissues.^^ 
Experimental intravenous inoculation of S19 leads to infection of the placenta and 
abortion. Two separate studies in the United States and United Kingdom utilized 
experimental intravenous inoculation of S19 in pregnant cattle in larger than recommended 
doses. ' S19 induced abortion in 100% of the cattle tested in both experiments. Abortions 
occurred between 16 days and 42 days after inoculation. 
In pregnant cattle inoculated by the traditional subcutaneous route, the incidence of 
abortion is less. In a Canadian smdy, the effects of subcutaneous S19 vaccination on 
58 pregnant cattle were investigated. Of 112 cattle vaccinated between one and nine months 
of gestation, 16 (14.29%) aborted. However, it was noted that of 30 cows between six and 
nine months of gestation, four (13.33%) aborted and S19 could not be recovered from 
58 
colostrum or uterine exudate in any of the four. 
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Not only is route of vaccination important but also vaccine dose. In cattle vaccinated 
during pregnancy with l/20th the reconunended dose of 1.12 x 10" and challenged with a 
virulent strain 10 weeks later, S19 was recovered in 4/9 (44%) following parturition with one 
abortion and one premature birth.^ Vaccination with l/400th the recommended dose caused 
no abortions and isolation of S19 in colostrum from 1/9 (11 %) cows." 
Some researchers have associated S19 colonization of the bovine placenta and 
abortion with erythritol utilizing mutants.^' In 4/9 (44%) pregnant cattle, vaccinated with 5.8 
X lO' S19 organisms, S19 was isolated from cotyledonary tissues and in 2 cows colonization 
led to abortion or premature calving. These two isolates were determined to be erythritol 
utilizing mutants of SI 9.^^ Similarly, 307 head of cattle, three to five months pregnant were 
o 
vaccinated with a dose of 3 x 10 S19 organisms and abortion occurred in 15 (4.9%) of the 
cows with four of the isolates being erythritol utilizing variants of S19. In spite of these 
findings which suggest that erythritol utilization is responsible for the placental tropism of 
S19 and other Brucella strains there is evidence to the contrary. Species which do not 
synthesize erythritol in placental tissues, i.e. humans, rats, mice, rabbits and guinea pigs can 
become infected with Brucella sp. and develop placentitis.^^'"'^ Moreover, rate of erythritol 
metabolism has not been correlated with increased virulence in Brucella sp.^^'^'* Therefore, it 
is likely that although erythritol may enhance Brucella growth, it is not essential for growth 
or placental infection. 
Large numbers of pregnant cattle can be vaccinated with S19 with minimal concern 
for large numbers of vaccine-induced abortions. In a Florida field trial, cows in late gestation 
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were vaccinated with S19 at a dose of lO" organisms / animal. Vaccination with S19 
induced abortion in less than 1% of over 10,000 cows.^' 
A small percentage of cows vaccinated with S19 as calves may retain S19 infection 
into adulthood and in some instances this persistent infection may be responsible for 
o/r 
abortion. A study in the United Kingdom showed that of 34 isolates of bovine origin 
86 determined to be SI9, 11 were from abortion material. Calfhood vaccination was the only 
known exposure to S19 in all cases. 
Virulence Factors 
Brucella with smooth colony morphology are more virulent than Brucella with rough 
TX 
colony morphology, and this suggests a significant role for LPS in the virulence of B. 
abortus. Both smooth and rough Brucella are able to enter host cells; however, rough 
Brucella may enter host cells more effectively.'^ Smooth Brucella survive and even multiply 
while the rough bacteria are eventually eliminated.^^ Survival of Brucella has been related to 
various factors including their ability to inhibit phagosome-Iysosome fusion,^" '® resist 
destructive effects of lysosomal enzymes after fusion has occurred,^" and inhibit TNF-a 
secretion by phagocytic cells. 
An important property of Brucella sp. is the ability to survive and multiply 
intracellularly in host phagocytes. Extracts from the smooth virulent B. abortus strain 2308 
are able to suppress phagosome-Iysosome fusion in murine peritoneal macrophages.^^ In 
bovine neutrophils, extracts of B. abortus strain 2308 show a concentration dependent 
10 
inhibition of primary granule release.This inhibition may be due to the production of 5' 
guanosine monophosphate (GMP) and/or adenine which are found in the culture supematant 
of live Brucella but not S. epidermidis or E. coli}^ Adenine and GMP have been shown to 
inhibit the ability of neutrophils to iodmate proteins.'^ Macrophage lysosomal release has 
also been shown to be inhibited by adenosine and other nucleosides and nucleotides most 
likely by inhibition of methylation of membrane proteins or phospholipids important in 
membrane fusion.^' Protein iodination and lysosomal release are important antibacterial 
mechanisms employed by phagocytes. Persistence of Brucella in phagolysosomes of 
nonactivated macrophages is thought to provide safety from host antibacterial factors. 
However, activated macrophages are able to phagocytose and kill Brucella. 
B. abortus has a predilection for the placental cotyledons, specifically the 
trophoblast.'^ Pathogenesis studies have shown that in placental infection, B. abortus is first 
seen in phagosomes of erythrophagocytic trophoblastic epithelial cells of the placentome. 
Following replication within erythrophagocytic trophoblastic cells, B. abortus next replicate 
within the rough endoplasmic reticulum cistemae and nuclear envelope of adjacent 
chorioallantoic cells of the trophoblast."* Hematogenous spread to chorionic villi and the fetus 
follow necrosis of trophoblast and ulceration of the chorioallantoic membrane. It remains 
unclear if Brucella are passively phagocytosed by the trophoblastic cells or if there is a more 
selective receptor-ligand interaction between the bacteria and trophoblastic cells. However, 
indiscriminate phagocytosis of Brucella would not account for the remarkable numbers of 
11 
bacteria within trophoblastic cells when few bacteria are seen free in the extracellular space, 
suggesting a more specific tropism for the placental trophoblast. 
Brucella sp. synthesize several proteins which have been determined to be important 
in protecting bacteria against the damaging effects of host cell enzymes including superoxide 
dismutase/'* catalase, and high temperature resistant stress proteins.^ Construction and 
testing of genetically altered B. abortus mutants deficient in the Cu-Zn superoxide dismutase 
gene, htrA heat shock gene, catalase gene, urease gene, recA gene or a gene encoding a 31-
kDa protein of unknown fimction have not resulted in mutants of decreased 
. , 83,I9,46J4.64 
virulence. 
Iron chelating siderophore synthesis is a virulence mechanism utilized by various 
pathogens to survive in the low iron environment of the host. In animal cells and body fluids 
free iron levels are low. Rather, iron is bound to host proteins such as transferrin and 
lactoferrin. Bacteria have developed proteins (siderophores) which scavenge iron from host 
48 iron binding proteins in low iron envirorunents. Brucella abortus has been shown to 
produce the siderophore 2,3-dihydrobenzoic acid when grown under iron-limiting situations 
in vitro.^^ However, the importance of siderophores in vivo has not been established. 
Enzymes such as nitric oxide are of limited importance in host defense against 
brucellosis. Addition of I-arginine, an inhibitor of nitric oxide synthesis, to Brucella-
infected macrophages in vitro has only minor affects on killing of Brucella?^ Nitric oxide 
has been shown to be important in resistance to infection with the intracellular parasite 
Leishmania.^^ 
12 
Placental lesions in cattle with brucellosis 
Early descriptions of gross lesions of brucellosis consisted of an abundant yellow 
exudate with a slimy, somewhat lumpy character found between the uterine mucosa and the 
allantochorion. This exudate contained numerous short bacilli.® Later microscopic 
descriptions reported necrosis of trophoblast cells and large numbers of intracellular bacilli 
within trophoblast cells. Uterine mucosal epithelial cells as well as amniotic epithelial cells 
were reported to be unaffected.'^ More recent and complete descriptions describe placental 
cotyledons with marked inflammation characterized by cell debris, intact and degenerate 
neutrophils and bacteria lying between the maternal caruncle and the allantochorion.®^ These 
changes in the placental cotyledon were limited to the periphery of the cotyledon early in 
infection (3-4 weeks after infection) and did not extend to the interior of the cotyledon until 5 
weeks after infection. Close examination of the trophoblast layer showed masses of bacteria 
within the trophoblast. Inflammation extended to the connective tissues of the allantochorion 
which was edematous and contained numerous neutrophils. Endothelial cells lining fetal 
blood vessels contained large numbers of intracellular bacilli. Maternal tissues of the 
placentome were largely unaffected.®® Additionally, a mild interstitial lymphoplasmacytic 
mastitis with acinar lumina variably filled with neutrophils was described in experimentally 
infected cattle.®® 
13 
Development and anatomy of the placenta 
Placental development begins early during the morula stage as the outer layer of 
ectodermal cells differentiate into trophoblastic cells. Trophoblastic epithelimn is 
differentiated to physically cormect the developing embryo with the uterus. Differentiation 
includes the redistribution of intercellular adhesion molecules such as E-cadherin and Na^/K^ 
ATPases to the basolateral aspect of the trophoblastic epithelial cell. Cadherins and ATPases 
are present on all cells in the morula, but redistribution occurs only in trophoblastic epithelial 
cells. The Na^/K^ ATPase may fimction in ion and fluid fluxes necessary to create the cavity 
of the blastocyst known as the blastocoel. Cytokeratins characteristic of epithelial cells are 
detectable in differentiating trophoblastic epithelial cells at this early morula stage. 
Remaining cells of the morula differentiate at one pole into the inner cell mass. Endodermal 
and mesodermal components of the placenta later develop from portions of the inner cell 
mass. The continued development of the remaining inner cell mass into the embryo does not 
proceed until the first structures of the placenta have been formed. Early in placental 
development and coincident with implantation, maternal recognition of pregnancy is 
required. In a broad sense, maternal recognition is the sequence of events required to ensure 
that the conceptus is not rejected by the maternal immune system. It is hypothesized that 
release of cytokines selectively modulates the immune cells at the implantation site. In some 
species, the release of factors from the placenta act in a paracrine or endocrine fashion to 
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ensure continued pregnancy. In ruminants the secretion of type I interferons from 
trophoblastic epithelial cells plays a key role in maternal recognition of pregnancy. 
Progesterone is required during pregnancy to maintain uterine endometrium in a 
secretory and receptive state which is optimal for embryonal growth and development. 
Therefore, it is vital during pregnancy to ensure the continued secretion of progesterone. The 
major source of progesterone is the postovulation ovarian structure the corpus luteum (CL). 
Since the gestational period for most species is longer than the functional period of the 
normal corpus luteum, during pregnancy it becomes necessary to extend the functional life of 
the CL. Different mammals utilize different strategies to extend CL function. Primates and 
horses produce a luteotrophic substance, chorionic gonadotropin, which supports the CL by 
supplementing the action of luteinizing hormone from the anterior pituitary. In ruminant 
species, a type I interferon, IFN-x, is produced by mononucleate trophoblastic epithelial cells. 
IFN-t inhibits prostaglandinF2a (PGF2a)-^ Prostaglandin F2a is produced by the uterus and 
serves to lyse the CL in nonpregnant animals. The expression of IFN-t mRNA occurs as 
early as postconception day 7, is maximal around days 16-19, and is limited to the 
mononucleate trophoblastic epithelial cells and has not been detected in binucleate 
frophoblastic cells, embryonic disc cells or embryonic endodermal cells.^ 
Implantation of the conceptus proceeds differently among different species. In 
rodents and primates, implantation occurs soon after the blastocyst hatches from the zona 
pellucida. In ruminants, swine and horses the conceptus remains free in the uterine lumen for 
several days before implantation. In rodents, the study of implantation has shown that 
15 
trophoblast - uterine attachment may be initiated by carbohydrate - lectin interactions. 
Mouse blastocysts have been shown to express several carbohydrate structures including the 
lectin ligand, sialyl lewis X which is also important in lymphocyte - high endothelial cell 
interaction in lymph node postcapillary venules. 
The maternal response to the implanting embryo includes vascular changes such as 
• • 89 
angiogenesis, vasodilation and increased permeability. Hypercellularity occurs as 
inflammatory cells (large granular lymphocytes, macrophages and 78+ T cells) are recruited 
to the implantation site.^°'^^ Several proinflammatory cytokines are produced in the uterus 
and increased angiogenesis is noted. In primates and rodents the uterine epithelium is lost, 
and poorly characterized stromal cells, decidual cells, undergo transformation and 
proliferation. This decidua contains numerous inflammatory cells such as macrophages, 
lymphocytes, natural killer cells and lymphocytes of the y/S subtype, y/6 T-cells have been 
shown to play a protective role on some mucosal surfaces and may be especially important 
78 in infections due to intracellular bacterial pathogens. 
Early steps in placental development and cell differentiation may proceed similarly 
between species; however, the degree of invasion of uterine tissues and the final form the 
placenta takes are quite variable. In primates and rodents the trophoblast invades maternal 
vasculature in the submucosa creating a hemochorial placenta. In the pig, the trophoblast is 
noninvasive and forms a diffiise apposition to the uterine epithelium resulting in a diffuse 
epitheliochorial placenta. In ruminants, the trophoblastic epithelium is noninvasive; 
however, some binucleate trophoblastic cells fuse with uterine epithelial cells forming 
16 
syncytia which then release granules of placental lactogen into the maternal circulation. 
Syncytia formation is more pronounced in small ruminants such as sheep and goats than in 
cattle. Intimate contact between chorionic trophoblast and uterine epithelium occurs in 
ruminants in specialized structures termed placentomes. The maternal contribution, the 
uterine caruncles, occur in four rows more or less evenly spaced in the uterus and are present 
in both uterine homs.''"^^"^' The bovine uterus contains approximately 100-160 caruncles.^^ 
The size of the placentome is dependent on stage of pregnancy and position in the uterus.'^ 
Nonpregnant, multiparous females and virgin heifers have well-defined caruncles composed 
of small cells with small, dense oval or spindle-shaped nuclei. Ultimately, these cells are the 
source of growing matemal connective tissue during the development of the placentome.^^ 
The expanding chorioallantoic membrane of the early embryo is apposed closely to 
the uterine wall, and in those areas apposing caruncles, the chorioallantoic membrane enters 
narrow spaces within the caruncle. The chorioallantoic membrane associated with caruncles 
forms thickenings described as "milky patches". These fragile attachments between caruncle 
and chorioallantois occur as early as 33 days after ovulation." The mesoderm of these 
patches contains thin walled allantoic blood vessels with primitive nucleated erythrocytes. 
The caruncular tissue forms a crypt system composed of numerous deep and extensively 
branched crypts which open toward the chorioallantoic membrane. Initially the crypts are 
filled with cell debris and erythrocytes while being lined by uterine epithelial cells. The 
corresponding chorioallantoic membrane forms villi with loose mesenchymal cores which 
are well vascularized by allantoic blood vessels. Villi are covered by a simple layer of 
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trophoblastic epithelium.'^" Trophoblastic epithelium comprises a heterogeneous 
population of erythrophagocytic, placentomal and chorioallantoic trophoblastic cells that 
differ in location and fimction. Chorioallantoic villi penetrate into a network of caruncular 
crypts. Villi advance through the caruncle until their tips reach the base of the caruncle. The 
trophoblastic and cryptal cells have surface microvilli which interdigitate with each other, 
thus increasing the sxirface area of contact between fetal and maternal tissues. " Primary 
chorionic villi run deep and straight to the base of the placentome, decreasing slightly in 
diameter toward the base. Branches of secondary and tertiary villi form, and interdigitate 
with maternal crypts of primary, secondary, and higher order. The bases of the primary villi 
form arcades around club-shaped endings of maternal septa." Further grovrth of the 
placentome comes from enlargement of the diameter and length of existing villi and/or from 
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extensive villus branching and increased surface corrugation. 
In ruminants, the placentomal arcade zone is the area between the base of primary 
chorionic villi and the tips of maternal septa. Within this space there is often extravasated 
blood, autolyzed cells and uterine secretions. This material is often resorbed by the adjacent 
trophoblast cells." In sheep, this zone has been studied extensively where extravasation of 
blood is significant and can be seen grosslyIn the bovine placenta the amount of 
extravasation is not as great; however, small deposits of blood are first noted in the third 
month of gestation and increase in volume during gestation. Erythrophagocytic chorionic 
trophoblastic epithelial cells in this zone contain erythrocytes in various degrees of 
degeneration as well as hemoglobin derived pigment.^"'" Erythrophagocytosis is thought to 
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be a major pathway of iron acquisition for the fetus as well as an important factor in the 
pathogenesis of placentitis and fetal infection in brucellosis infection in goats'* and sheep/^ 
The intercotyledonary area is situated between placentomes and is comprised of a 
maternal side of glandular uterus lined on the surface by simple epitheliiun of varying height. 
The fetal side is represented by the allantochorion which is sometimes folded. The surface 
facing the maternal side is lined by trophoblast. Trophoblastic epithelial cells opposite the 
surface openings of uterine glands are also highly phagocytic, ingesting uterine secretions. 
Pathogenesis of bovine abortion 
Both maintenance and termination of pregnancy involve a complex interplay between 
fetus, placenta, uterus and various fetal and maternal endocrine control mechanisms. Any of 
these factors must be considered a potential target of any abortifacient. Further complicating 
the scenario are species differences concerning known abortifacients. For example, the 
abortifacient activity of PGF2a in rats is largely due to the disturbance of luteal function 
while in guinea pigs, PGF2a causes abortion due to oxytocic effects on uterine contractility."^ 
The definitive mechanism of abortion in brucellosis is unknown. Fetal death and 
abortion may be due to interruption of nutrient and oxygen transfer by the placenta and 
subsequent fetal hypoxia;however, rats infected with Brucella abortus or Listeria 
monocytogenes showed large areas of placental necrosis but no fetal death. However, if 
placental destruction was extreme, survival was not possible.^^ These findings suggest that 
more than disruption of the fetal maternal interface is involved in brucellosis abortion. 
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Another hypothesis involves the toxic effects of endotoxin, including increased 
uterine sensitivity to oxytocin following exposure to Brucella endotoxin.^'* As early as 1943 
endotoxin was found to be a potent abortifacient. Placental hemorrhage and abortion in mice 
and rabbits was demonstrated following intraperitoneal injections with Shigella 
paradysenteriaeP It was hypothesized that decidual and placental capillaries have a much 
lower threshold of damage due to endotoxin than vessels of other organs.'^ Investigators 
later described fibrinoid swelling in the placental interstitium in addition to placental 
hemorrhage and abortion in mice and rabbits following administration of endotoxin. These 
findings led to the suggestion that endotoxin caused a Shwartzmann-like reaction in the 
placenta resulting in abortion. This idea was later discounted when it was found, by other 
researchers, that there were areas of hemorrhage in the decidua basalis in untreated mice at 
term as well as endotoxin-treated mice.^^ This finding suggested that this histologic change 
represented a mechanism by which normal placental separation proceeded and not a change 
specific for endotoxin-induced abortion. A finding which was not seen in control mice; 
however, was vascular engorgement of the placental labyrinth. 
Cattle given LPS during gestation abort within 10 days; however, the fetus does not 
appear to play a significant role in endotoxin-induced abortion.^' Several parameters were 
evaluated in pregnant cattle following intravenous infusion of Salmonella typhimurium LPS 
using catheterized fetal and placental structures.^' Maternal responses included increases in 
PGF2a, TNFa, ACTH, Cortisol and decreases in leukocytes and progesterone with rapid 
clearance of endotoxin firom maternal plasma. Fetal changes included increases in ACTH 
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and Cortisol with delayed increases in PGE2 in amniotic and allantoic fluids and no elevations 
of fetal TNFa levels and no detection of LPS in fetal plasma. No gross or microscopic 
lesions were seen in the fetuses and fetal motion and blood O2 levels were normal up to the 
time of abortion. These findings do suggest; however, a possible role for increases in PGF2a, 
TNFa or Cortisol in endotoxin induced abortion. 
The luteolytic effect of PGF2a may play a more important role in early first trimester 
abortion rather than in abortions which occur during the second or third trimester, more 
typical of brucellosis.^^ In cattle, pregnancy during early gestation is maintained primarily 
by progesterone secreted by the CL. In advanced gestation, extraluteal sources of 
progesterone, such as the placenta, predominate.^' One report showed cows in the first 
trimester of pregnancy are more sensitive to the abortigenic effects of LPS than are cows in 
the second or third trimester.^^ The increased sensitivity of first trimester cows may be 
attributable to the lack of extraluteal sources of progesterone. The oxytocic effects of PGFia; 
however, could play a role in abortion at any stage. In humans, LPS inhibits prostaglandin 
dehydrogenase, the prostaglandin inactivating enzyme creating a net increase in 
prostaglandins.^'' 
Gram negative bacterial invasion of placental and uterine tissues in humans is 
characterized by the release of bacterial LPS and phospholipases from bacterial and placental 
sources. Phospholipases cause the release of arachidonic acid and subsequent elevations in 
78 prostaglandins as well as the induction of cytokines. Metabolism of PGE2 from human 
amnion cells has also been shown to increase during term as well as pathogen -induced 
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labor.' The role of prostaglandins in the initiation of term and preterm parturition are 
supported by several observations: 1) prostaglandins cause cervical ripening and uterine 
contractions; both necessary preparatory changes for fetal expulsion, 2) the precursor of 
prostaglandins, arachidonic acid, is found in increased levels in the anmiotic fluid of laboring 
women, 3) injection of arachidonic acid into the amnion stimulates labor, and 4) inhibitors of 
prostaglandin synthesis inhibit parturition. 
In addition to the effects of LPS mediated through prostaglandins, maternal 
endotoxemia results in the stimulation of both the fetal and maternal hypothalamic - pituitary 
- adrenal axes.^^"^' This results in a sharp rise in fetal and maternal adrenocorticotrophic 
hormone (ACTH) and Cortisol. Activation of this response in normal term pregnancies in 
ruminants is thought to initiate the physiologic process of parturition.^" 
Increased Cortisol values have been noted in fetuses inoculated with virulent B. 
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abortus as early as PID 6; therefore, this may play a role in premature labor as Brucella 
organisms multiply within trophoblastic cells. As trophoblastic cells are shed into the 
inflammatory exudate, high numbers of organisms can potentially be achieved. As local LPS 
and prostaglandin concentrations increase, parturition may be induced. 
A strong correlation between prostaglandin levels with TNF-a and IL-1 levels in 
amniotic fluid has been noted in women during preterm labor.'^ It is well known that LPS 
can cause the release of cytokines such as TNF-a and IL-1 from macrophages; furthermore, 
23 TNF-a stimulates prostaglandin synthesis by several cell types. The significance of 
uteroplacental TNF-a is not entirely clear, but it likely involves the following; regulation of 
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cell proliferation at the uteroplacental interface (TNF-a inhibits DNA synthesis of 
trophoblastic cells), regulation of expression of MHC-I antigens necessary for the binding of 
many hormones and growth factors, and elevated levels of TNF-a have been implicated in 
the initiation of preterm labor associated with infection in women/'^^ 
In humans epidemiological, bacteriologic and histologic evidence for the association 
of bacterial infection and preterm labor exists. Prenatal association of specific infectious 
agents and preterm labor are suggestive but inconsistent. These agents include, Neisseria 
gonorrhea, group B streptococci. Chlamydia trachomatis. Mycoplasma hominis, Ureplasma 
urealyticum, and Trichomonas vaginalisJ'^ 
Histologic evidence of an association of infection and inflammation with preterm 
labor has been reported.'*^ Histologic findings such as these, as well as bacteriologic findings 
can be debated on the argument that bacteriologic and tissue changes may have occurred after 
labor. However, studies in which measurements of the onset of uterine contractions and 
membrane integrity were controlled, show that histologic and microbiologic changes occur 
prior to the initiation of parturition.''^ 
A potential model is hypothesized in which bacterial infection of uterine and/or 
placental tissues occurs. Bacterial factors such as LPS activate the host monocyte 
macrophage system to produce TNF-a as well as other proinflammatory cytokines. TNF-a 
and other cytokines stimulate the release of prostaglandins from intrauterine tissues which 
signal the initiation of parturition.^' This model is supported by the detection of measurable 
TNF-a in >90% of women with preterm labor and amniotic fluid from which bacteria were 
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cultured. TNF-a was not detected in amniotic fluid from women during the second and third 
71 72 trimesters who were not in labor. ' This model is not without opponents. Other 
researchers have found that amniotic fluid TNF-a levels increase during pregnancy and 
normal parturition as well as preterm labor.'^^ This same study showed no detectable changes 
in plasma TNF-a of pregnant women at any time during gestation. 
The cellular origin of uteroplacental TNF-a is also not completely understood. In 
vitro studies have shown the release of TNF-a by decidual and chorionic villi explants, 
cytotrophoblast cells in culture, dispersed amniochorion cells and macrophages isolated from 
chorionic and decidual tissues."*^ 
In ruminants, TNF-a levels rise following the intravenous infusion of endotoxin. 
Chronic administration of endotoxin to cattle results in depression, cachexia, and diarrhea 
with renal hemorrhage and interstitial nephritis, thymic atrophy, myocardial atrophy and 
subendocardial hemorrhage, skeletal muscle atrophy, serous atrophy of fat, lymphoid 
depletion, hepatic necrosis and vacuolar change, pancreatic necrosis and ileal villus 
atrophy In periparturient cattle, isolated mononuclear cells are more responsive to the 
effects of endotoxin, producing more TNF-a, than those of cows in mid to late lactation.^' 
Furthermore, supramammary lymph node mononuclear cells were more responsive to 
endotoxin than those from the peripheral blood.'' The role of increased mononuclear cell 
responsiveness to the effects of endotoxin in periparturient diseases such as late term 
abortion, endometritis and mastitis is unclear; however, it may provide insight into the high 
prevalence of these periparturient diseases of cattle. 
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In addition to the uterine synthesis of prostaglandins stimulated by proinflammatory 
cytokines, the luteolytic action of PGF2a may also be mediated through TNF-a. Using a 
procedure known as continuous flow microdialysis, it has been shown in vivo, that TNF-a is 
increased in luteal tissue coincident with a decline in progesterone/^ Immunohistochemical 
studies have localized the source of luteal TNF-a to macrophages within the CL. These 
findings suggest that the luteolytic action of PGF^a may, in part, be mediated through TNF-
a. 
68 Tumor necrosis factor is increased in the milk of dairy cattle near parturition. Milk 
TNF-a levels peak 4 to 6 weeks prior to parturition and decrease to undetectable levels at 
parturition. Following parturition, TNF-a levels increase rapidly and maintain a midlevel 
68 
concentration throughout lactation. It is not noted if plasma TNF-a levels follow a similar 
pattern as those seen in the milk; however, it is assumed that the source of the TNF-a is the 
68 increased number of macrophages in milk which parallel the increase in TNF-a. 
Dissertation Organization 
This dissertation is prepared in the alternate format and includes manuscripts prepared 
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CHAPTER 2. EXPERIMENTAL INFECTION OF PREGNANT CATTLE 
WITH THE VACCINE CANDIDATE BRUCELLA ABORTUS STRAIN RB51: 
PATHOLOGIC, BACTERIOLOGIC AND SEROLOGIC FINDINGS 
A paper published in Veterinary Pathololgy 1996;33:682-691 
Mitchell V. Palmer, Norman F. Cheville, and Allen E. Jensen 
Abstract-
To determine the placental tropism and abortigenicity of the vaccine candidate, B. 
abortus strain RB51 (SRB51), a rough mutant of the virulent strain 2308, 10 Polled Hereford 
heifers were inoculated intravenously in the sixth month of gestation. Heifers were 
euthanatized and examined at 8 weeks p.i.(n=5) or at full term (n=5). Four of five infected 
heifers sampled at 8 weeks p.i. and 3/4 infected heifers at term had placentitis while 
reproductive tissues of 3 normal cows used for comparison had no placentitis. Numerous 
macrophages, immunoreactive for SRB51 antigen, as well as neutrophils, fibrin and cell 
debris filled the arcade zone between chorion and maternal septae. Trophoblastic epithelium 
of the placentomal arcade zone had intracellular bacteria that were immunoreactive for 
SRB51 antigen. The tips of matemal septae had a lymphoplasmacytic infiltrate with small 
multifocal erosions and ulcerations of matemal epithelium. SRB51 was cultured fi-om all 
tissues in which lesions were seen. Placentae of one cow from each group had no placentitis 
and contained no SRB51. In mammae, interstitial lymphoplasmacytic infiltrates and 
suppurative infiltrates within alveoli and intralobular ducmles were seen in 2/5 heifers at 8 
weeks p.i. SRB51 was cultured firom liver, spleen, lung and bronchial lymph nodes in 4/5 
calves at 8 wks. p.i. and 3/4 full term calves, but no lesions were seen. One term heifer had 
disseminated infection, placentitis, lymphoplasmacytic endometritis, and delivered a 
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premature weak calf. These results establish that SRB51 is less abortifacient than previously 
published reports with strain 19, in that only 1/4 heifers delivered prematurely following 
intravenous inoculation with SRB51 while intravenous inoculation with strain 19 leads to 
100% abortion. However, it also shows that SRB51 can infect the bovine placenta, 
mammary gland and fetus; can induce placentitis and in some cases, lead to preterm 
expulsion of the fetus. 
Introduction-
The eradication of bovine brucellosis has centered on the use of Brucella abortus 
strain 19 (SI9), an attenuated, live vaccine introduced into the federal brucellosis eradication 
program in 1940. Although effective and important in the control of bovine brucellosis, S19 
has significant limitations including virulence for humans, ability to induce abortion in 
6,11_30 
pregnant cattle, and the development of agglutinating antibodies indistinguishable from 
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those seen in naturally infected animals. 
Experimental intravenous infection of pregnant cattle using S19 typically leads to 
placentitis and abortion; e.g. in two separate studies abortions occured in 100% of the 
cows.^^"''^ Abortion occured as early as 16 days and as late as 42 days postinoculation."*^ 
Additionally, in one of the preceeding studies, B. abortus strain 45/20, given intravenously 
caused abortion in 100% of the cows between days 9 and 47 after inoculation. A separate 
study utilizing B. abortus strain 544 resulted in abortion in 100% of the cows in 3-4 weeks 
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when given intravenously. B. abortus S19 has also been shown to induce abortion in a 
small percentage of pregnant cattle vaccinated subcutaneously with the normal vaccine 
dose.^-'^-^° 
B. abortus strain RB51 (SRB51) is a stable rough mutant of B. abortus strain 2308 
37 (S2308), which lacks much of the LPS 0-side chain, and has been investigated as an 
g 
alternative vaccine to S19. A major concern m evaluating SRB51 is the possibility of 
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tropism for the bovine placenta and subsequent abortion. In mice, SRB51 has been shown to 
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produce a mild to minimal placentitis which is not associated with fetal death. Although 
SRB51 did localize in the giant trophoblast cells of the mouse placenta similar to S19 and 
the virulent S2308, placental damage and colonization by SRB51 were markedly less than 
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with either S19 or S2308. Further testing has shown that SRB51 did not induce abortion in 
pregnant goats when fetuses were inoculated intramuscularly with SRB51.^^ SRB51 was 
found to colonize bovine chorioallantoic membrane explants in a manner similar to S19 and 
S2308; however, the degree of cytotoxicity associated with SRB51 infection was much less 
than that meastired for S2308 infection and not significantly different firom that seen with 
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S19. 
The abortifacient potential of SRB51 in pregnant cattle has not been determined. It is 
essential that SRB51 or any other vaccine candidate be tested in cattle to determine the 
ability to not only cause abortion but any other pathologic changes which may be considered 
detrimental. The purpose of this study is to determine the potential for abortion, placental 
infection, placentitis and fetal infection in pregnant cattle infected with SRB51. 
Materials and Methods-
Ten virgin Polled Hereford heifers used in the experiment were obtained from 
nonvaccinated, brucellosis-free herds. Six heifers were 27-months old while the remaining 4 
were 16 months old at breeding. All cattle were serologically negative for brucellosis by 
standard tube agglutination."* Upon arrival, cattle were kept on pasture and bred by natural 
service using a Polled Hereford bull which was also serologically negative for brucellosis by 
standard tube agglutination. During challenge, animals were housed individually as 
described^ in concrete isolation rooms with positive air flow from a clean corridor and 
negative air flow to a contaminated corridor. 
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Normal tissue for comparison was obtained from a meat packing plant. Three 
reproductive tracts containing fetuses estimated by fetal crown-rump length to be 
approximately 240 days gestation were collected, processed for light microscopy and 
examined. 
At 6 months of gestation, heifers were injected intravenously in the right jugular vein 
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with 10 CFU B. abortus stram RB51 suspended in 10 ml sterile saline (0.85% NaCl). At 
postinfection week 8 (PIW), 5 heifers (3 from older group and 2 from younger group) were 
randomly selected, euthanatized and examined. The remaining cattle were examined at term 
(n=3) or following premature delivery (n=l). Samples of maternal uterus, placentomes, 
intercotyledonary placenta, mammary gland, supramammary lymph node, liver, spleen, and 
fetal liver, spleen, lung and bronchial lymph node were obtained for bacteriologic culture, 
histopathology and immunohistochemical staining for SRB51 antigen. Matemal blood, milk, 
vaginal swab, allantoic and arrmiotic fluids and fetal blood, cerebrospinal fluid, abomasal 
contents and rectal swab, were also collected for bacterial culture. All cattle were 
euthanatized by intravenous administration of sodium pentobarbital. 
Following a premature delivery, heifer (#9) was treated with oxytetracycline 
(Liquamycin LA-200, Pfizer, New York, N.Y.), 1 Img/kg, SID for 5 days prior to necropsy. 
Treatment of cows aborting or delivering premature calves has been standard protocol in our 
laboratory as a matter of personnel safety due to the zoonotic potential of B. abortus and the 
unknown virulence of SRB51 for humans. 
Histologic and Immunohistochemical analyses- Tissue specimens were placed in 10% 
neutral buffered formalin. Tissues were processed by routine paraffin embedment 
techniques, cut 4-6 [am thick and stained with hematoxylin and eosin. Unstained sections 
were used for immunohistochemical staining of SRB51 antigen using an avidin-biotin-
25.32 
alkaline phosphatase complex staining techmque as described and a commercially 
44 
available kit (Histomark, BCirkegaard and Perry Laboratories, Inc., Gaithersburg, MD). 
Primary antibodies were prepared by hyperinununization of rabbits with whole cell, 
irradiated SRB51. Anti-SRB51 antisera was used at a dilution of 1:1000. Optimal dilutions 
for the primary antibody had previously been determined using formalin-fixed, paraffin-
embedded sections of SRB51-infected murine spleens or bovine lymph nodes. Control slides 
were stained with serum from clinically normal rabbits. Sections of SRB 51-infected 
BALB/c mouse spleen and liver were used as positive control slides. Staining of bovine 
macrophages using the monoclonal antibody EBM 11 (anti-CD68) (Dako, Carpenteria, CA) 
was done as described.' 
Samples of placentome and intercotyledonary placenta were also collected, embedded 
in O.C.T. compound (Tissue Tek, Miles Scientific, Naperville, IL) and immediately frozen 
by immersion in liquid nitrogen. Frozen sections of intercotyledonary placenta and 
placentome were processed and stained with monoclonal antibodies to CD4, CDS and y/5 
lymphocyte surface markers as described."' 
Bacteriologic analysis- B. abortus strain RB51 was used in this study.SRB51 was 
prepared from master seed stock of B. abortus RB51 (ARS-1) at the Brucellosis Research 
Unit, National Animal Disease Center, Ames, lA. SRB5I was propagated from working 
seed stock on tryptose agar and incubated at 37°C for 48 hours. The surface of the agar was 
flooded with saline and the suspended bacteria were collected by aspiration, twice washed by 
centrifiigation and resuspended in saline. Bacterial suspensions were subsequently diluted to 
the appropriate concentration prior to inoculation. 
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Tissue samples to be tested for SRB51 were processed as described using tryptose 
agar with 5% bovine serum, cyclohexamide (30|ig/ml), bacitracin (7.5 U/ml), polymyxin B 
sulfate (1.8 U/ml) and ethylviolet (1:300,000). Brucella colonies were identified as described 
previously.^ 
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Collection and handling of bloodfor culture- At time periods corresponding to 
postinoculation day (PID) 1-6 and postinoculation week (PIW) 1-12, 100 ml of blood was 
collected aseptically for culture from jugular veins on alternating sides beginning with the 
side contralateral to the initial injection. The samples consisted of one 125 ml serum vial 
containing 50 ml of blood and 50 ml of blood culture media,^ and 5 - 20 ml tubes each 
containing 10 ml of blood and 10 ml of blood culture media. Upon receipt, 5 ml of blood 
was drawn aseptically from the 125 ml serum bottle and 1 ml was inoculated on to each of 5 
plates containing tryptose agar with 5% bovine serum. These plates were incubated at 11^C 
and checked at 24 hrs., 3, 7,10 and 14 days for bacterial growth. Any suspect growth was 
subcultured and processed for SRB51 identification. The remaining sample in the 125 ml 
serum vial was incubated at 37°C and subcultured as above on days 3,10, 20, 30 and 40. 
The 5 serum tubes were immediately placed at -20°C and kept until placed in biphasic 
flasks.^ Frozen blood was thawed at 37°C and transferred to biphasic culture flasks 
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containing tryptose agar and processed as described. These flasks were checked for bacterial 
growth at 24 hrs., 3, 7, 10,20, 30 and 40 days. Suspect growth was subcultured and 
processed for SRB51 identification. Calf blood was examined similarly at necropsy. 
Serological analysis- Twenty milliliters of blood was collected by venipuncture from 
each heifer prior to inoculation and PIW 1, 2,4, 6, 8, 10 and 12. Blood was collected into 
sterile 10-ml tubes, allowed to clot for 6-24 hrs. at 4°C, and centrifiiged. Serum was divided 
into 2 ml aliquots, frozen, and stored at -70°C. Blood was similarly collected from the 
calves at necropsy. Samples were later thawed and tested. The standard tube agglutination 
test was performed on all samples. Antibodies to SRB51 were measured by use of an 
antibody dot blot assay ^ using anti-bovine IgG, heavy chain specific and anti-bovine IgM 
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antibodies (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) at dilutions of 1:1,000 and 
1:100 respectively. 
Results -
Clinical Signs - Eight of ten cattle were febrile during the first 24-48 hours after 
inoculation. Elevated temperatures ranged from 39.1°C to 41.1°C (normal range 38.5±0.5 
°C). Six of eight heifers returned to normal body temperature by 24 -48 hours after 
inoculation; however, two heifers (#4 and #9) had elevated body temperatures which 
persisted for 72 hrs., being normal by 96 hours after inoculation. Febrile responses were not 
accompanied by other notable clinical signs. All cattle remained on feed and no obvious 
signs of depression were noted. 
One heifer (#9) delivered a premature, small, weak calf, one month prior to the 
expected calving date (PID 59). The calf was unable to stand or nurse and had a weak 
suckling reflex. The dam was afebrile at the time of delivery. 
Bacterial Culture of Blood- SRB51 was detected in blood in one or more sampling 
times up to 6 days after inoculation in 8/10 cattle, however, no organisms were cultured 
beyond that time (Table 1). Two of ten heifers showed no SRB51 in the blood at any 
sampling time. Calf blood culture revealed 2/10 calves contained SRB51 in the blood (Table 
2). 
Bacterial Culture of Tissues and Fluids- Four of five heifers (80%) sampled at PIW 8 
had SRB51 in placentomes, intercotyledonary placenta, uterus and spleen (Table 3). 
Mammary tissue and supramammary lymph nodes from 2/5 (40%) yielded SRB51. One 
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Table 1. Isolation of B. abortus strain RB51 from blood' of pregnant cattle inoculated i.v. at 
six months of gestation. 
ID PID 
1 2 3 4 5 6 
I + + - ND" ND -
2 - - ND ND + 
3 + - ND ND -
4 + - +•' + ND 
5 - - - ND 
6 + - - ND ND -
7 + + + ND ND -
8 . - _ ND 
9 ND 
1 0 
' Unless otherwise stated, B. abortus RB51 isolation was successful only after culture 
enhancememt (see text for details). 
'' ND = cow not tested on specified day. 
° B. abortus RB51 isolated from direct plating, 4.16 x 10" CFU/ml blood. 
•* B. abortus RB51 isolated from direct plating, one colony. 
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heifer was free of SRB51 by PIW 8. The calf from this heifer was also free of SRB51 in all 
tissues and fluids cultured. Bacteriologic culture of 4/5 (80%) calves from heifers 
euthanatized at PIW 8 showed SRB5I in liver, spleen, lung and bronchial lymph node (Table 
2). 
Three of four heifers (75%) which went to full term had SRB51 in samples of uterus, 
placenta and placentome (Table 3). One heifer which went to frill term was negative for 
SRB51 in all tissues and fluids cultured. The calf from this heifer was similarly free of 
SRB51. All other full term calves had SRB51 in spleen and bronchial lymph nodes. Two of 
four calves (50%) also had SRB51 in limg (Table 2). 
After the premature delivery of a weak calf, SRJB51 was found in milk samples from 
all four mammary quarters of heifer #9. A vaginal swab and samples of expelled placenta 
also contained SRB51. After oxytetracycline therapy for 5 days, SRB51 was still recovered 
from intercaruncular uterus and caruncle. No SRB5I was found in milk or mammary tissue 
following antibiotic therapy (Table 3). The premature weak calf was euthanatized within 8 
hours of delivery and examined. All samples cultured from the calf contained SRB51 except 
cerebrospinal fluid and a rectal swab specimen (Table 2). 
Serology- Ail heifers and calves had no antibody titers as determined by standard 
tube agglutination at all time points sampled. Serologic results measured by dot blot assay 
are reported in Table 4. No calf from either group had an antibody titer, as measured by the 
dot blot assay, for anti-SRB51 IgG antibody. The premature calf (#9) had an IgM titer to 
SRB51 of 1:160 at necropsy. Other calves had no anti-SRB51 IgM antibody titer. Anti-lgM 
titers were not evaluated on the heifers. 
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Table 2. Summary of culture results to isolate B. abortus RB51 from calves of pregnant 
heifers inoculated i.v. with RB51 at six months of gestation. 
PIW 8 Full term 
Animal Number 
Tissue 1 2 J 4 5 Total 6 7 8 9 10 Total 
Liver - + + + ND' 3/4 + - + + 3/5 
Spleen + + + + - 4/5 + - + + 3/5 
Lung + + + + - 4/5 + - + - 2/5 
Bronchial LN*" + + + + - 4/5 + + + + 4/5 
Blood - - - - - 0/5 + - + - 2/5 
CSF' - - - - - 0/5 - - - ND - 0/4 
Abomasal - + - + - 2/5 - - - NA" + 1/4 
Contents 
Rectal Swab - - + - - 1/5 + - 4- + 3/5 
'' Tracheobronchial lymph node. 
Cerebrospinal fluid. 
Not available for culture. 
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Table 3. Summary of culture results to isolate B. abortus RB51 from pregnant heifers 
inoculated i.v. at six months of gestation and examined at PIW 8 or at fiill term. 
Animal Number 
PIW 8 Full Term 
Tissue 1 2 3 4 5 Total 6 7 8 9' 9 10 Total 
Pre Post 
Liver + + - + -3/5 + +- na** ND" + 3/4 
Spleen + + + +.4/5 + +. na - + 3/5 
Uterus + + + +-4/5 + +- NA + + 4/5 
Placenta + + + +-4/5 + +- + na + 4/5 
Placentome + + + + -4/5 + +- + na + 4/5 
Mamm-'-RF - - + - - 1/5 - - - NA - - 0/5 
Mamm-RR - - + - - 1/5 - - - NA - + 1/5 
Mamm-LF + - -- .1/5..- nA - - 0/5 
Mamm-LR + - - - - 1/5 - - - NA - - 0/5 
LN'-R 0/5 - - - NA - + 1/5 
LN-L + - + - - 2/5 + - - NA - + 2/5 
Milk-RF 0/5 - - - + - - 1/5 
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Table 3 (continued). Summary of culture results to isolate B. abortus RB51 from pregnant 
heifers inoculated i.v. at six months of gestation and examined at PIW 8 or at full term. 
Animal Number 
PIW 8 Full Term 
Tissue Total 6 10 Total 
Pre Post 
Milk-RR 0/5 4- 1/5 
Milk-LF 0/5 1/5 
Milk-LR 0/5 1/5 
Blood 0/5 0/5 
Allantoic*^ ND + + 2/4 + NA NA NA + 2/3 
Amniotic® 0/5 NA NA NA + 1/3 
VS" ND 0/4 1/5 
' Pre and post samples refer to oxytetracycline treatment given after premature delivery of a 
weak calf. 
'• NA = not available for culture. 
" ND = not done. 
Mamm = mammary gland tissue. 
' LN = supramammary lymph node. 
^Allantoic fluid. 
® Amniotic fluid. 
'* Vaginal swab 
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Gross Lesions - Mild placentomal edema was present in 4 of 5 cattie at PIW 8. The 
chorioallantois covering caruncles was mildly thickened, but translucent. Placentomes of 4/5 
cattle at PIW 8 contained a small amount of tan, creamy exudate found between the 
chorioallantois and maternal tissues. This exudate was most prominent over caruncles 
although it was found less frequently in intercotyledonary areas. Gross lesions were not 
present in other organs. Amniotic and allantoic fluids appeared normal. 
Placentae from 3/4 cows exammed at full term were more edematous than those 
examined at PIW 8 with thick gelatinous edema of the intercotyledonary placenta which 
was slightly opaque but translucent. Extensive areas of creamy, tan exudate were between 
the chorioallantois and uterine epithelium within placentomes and intercotyledonary areas. 
Allantoic and amniotic fluids appeared normal. 
The cow delivering a premature calf had cotyledons covered with a brown creamy 
exudate while the intercotyledonary areas were normal. Postparturient lochia contained small 
amounts of brown, creamy exudate. 
Microscopic Lesions-
PIW 8 - Placentitis was present in 4/5 cattle examined at PIW 8 (Figures 1,2). 
Infiltrates of numerous macrophages, neutrophils, necrotic cell debris and 
fibrinchemorrhagic exudate was seen in the placentomal arcade zone. Inflammatory infiltrate 
separated the tips of matemal septa from the trophoblast layer. Epithelial cells of the 
trophoblast contained abundant intracytoplasmic bacteria which were immunoreactive with 
anti-RB51 antibody (Figure 3). Many trophoblastic epithelial cells with intracellular bacteria 
were detached from the chorion and present in the inflammatory infiltrate. In some areas of 
intense inflammation, the trophoblast layer of the chorioallantois was flattened with cuboidal 
to squamous rather than columnar epithelial cells. Immunostaining for SRB51 showed 
intense staining within trophoblastic epithelial cells as well as within macrophages as a 
Figure 1. Section of placentomal arcade zone from a heifer examined at PIW 8. Note 
extensive inflammatory infiltrate separating chorioallantois (short arrow) from maternal 
septa (long arrow). HE. Bar= 100 |im. 
Figure 2. Section of placentome from a heifer examined PIW 8. Note chorionic villus 
surrounded by inflammatory cells and necrotic cell debris. Trophoblastic epithelial cells 
are enlarged and granular in appearance due to numerous intracellular bacteria (arrows). 
HE. Bar = 50 fim. 

55 
component of the inflammatory infiltrate. SRB51 immunoreactive macrophages were most 
prominent adjacent to the tips of the maternal septa and were rarely seen adjacent to the 
trophoblast layer (Figure 4). Neutrophils were seen in the tunicae intima and muscularis of 
arterioles of the chorioallantois with fewer located in the stroma of the chorioallantois. 
Endothelial cells of chorioallantoic arterioles were rounded with some containing clear, 
smoothly contoured cytoplasmic vacuoles. Bacteria immunoreactive for SRB51 were not 
seen within maternal septal epithelial cells of the placentome. Tips of maternal septa 
contained areas of lymphoplasmacytic infiltration with mild to moderate fibrosis. Small 
ulcerations of maternal septa were seen with loss of maternal epithelial cells, infiltrates of 
moderate numbers of neutrophils and small numbers of bacteria which were immunoreactive 
for SRB51 antigen. Intercotyledonary placenta had similar placentitis to that seen in 
placentomes with inflammatory infiltrate which separated maternal and fetal tissues. 
Foci of endometritis subjacent to areas of placentitis contained infiltrates of numerous 
lymphocytes, plasma cells, macrophages and neutrophils. These infiltrates were most intense 
in the strata compactum and spongiosimi but also extended deep to surround uterine 
submucosal glands. Immunostaining of T-lymphocytes in the endometrial inflammation 
revealed most to be of the CD4 type, with few present of the CDS or y/S (CD4- CD8-) 
subtype (Figures 5a, 5b). Infiltrates of neutrophils and fibrin were in submucosal glands of 
the uterus (Figure 6). Low numbers of submucosal gland epithelial cells, neutrophils and 
macrophages vvath cytoplasmic staining for SRB51 antigen were seen within and surrounding 
submucosal glands. 
Mammary glands had multifocal interstitial lymphoplasmacytic infiltrates and 
intraluminal infiltrates of large numbers of neutrophils within some alveoli and intralobular 
ductules. Supramammary lymph nodes had infiltrates of large numbers of macrophages and 
neutrophils in medullary sinuses which extended superficially to the deep cortex. Cortical 
regions contained prominent follicles with germinal centers. 
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Figure 3. Placentome from full tenn heifer, chorionic villus. Note extensive intracellular 
staining for SRB51 antigen. Avidin-biotin-alkaline phosphatase method. Gill's hematoxylin 
counterstain. Bar = 35 |im. 
Figure 4. Placentome from fiill term heifer, matemal septa (arrow). Note extensive 
inflammatory cells occupying space between chorioallantoic membrane and matemal septa 
which stain positive for SRB51 antigen. Avidin-biotin-alkaline phosphatase method. Gill's 
hematoxylin counterstain. Bar = 50 jim. 
Figure 5. Section of uterus from heifer at PIW 8. Periglandular lymphocytic infiltrate is 
composed primarily of CD4+ T-cells (a), with rare y/S T-cells (arrow)(b). Avidin-biotin-
alkaline phosphatase method. Gill's hematoxylin counterstain. Bar = 35 [im. 
Figure 6. Section of uterus from full term heifer. Note periglandular inflammation and 
intraluminal neutrophils. HE. Bar = 50 |im. 
\ 
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Maternal spleens had large numbers of macrophages with abimdant cytoplasm which 
separated white pulp areas and obliterated red pulp. These cells stained strongly for the 
macrophage marker CD68. Areas of lymphoid follicle formation in white pulp were normal. 
Calves examined at PIW 8 contained no significant microscopic lesions. In spleens, 
red pulp was well developed, periarteriolar lymphoid sheaths were small, and germinal 
centers were absent. 
Full term - Placentae from 4/5 full term cows had placentitis resembling that seen at 
PIW 8. However, placentitis was more widespread and extended deeper into the placentome 
involving not only the arcade zone but primary chorionic vilU and maternal epithelium and 
stroma. Bacterial colonies, immunoreactive for SRB5I antigen, were seen among the 
inflammatory infiltrate separating trophoblast from maternal septa. Immunostaining for 
SRB51 antigen showed results similar to those seen at PIW 8 with abundant staining of 
trophoblast epithelial cell cytoplasm. Similar microscopic lesions were observed in other 
organs as those seen in cows examined at PIW 8. As with the calves examined at PIW 8, 
full term calves showed no splenic germinal center formation and small periarteriolar 
lymphoid sheaths. No other gross or microscopic lesions were seen in full term calves. 
Extensive necrosis was seen in placentomes from heifer # 9 which delivered a 
premature weak calf. Necrosis of chorioallantois and trophoblastic layers extended deep to 
the base of the placentome. Aggregates of basophilic coccobacilli between trophoblastic and 
matpmfll septal epithelium were immunoreactive for SRB51 antigen. Endometritis 
characterized by infiltrates of large numbers of lymphocytes, plasma cells and neutrophils 
was present in the superficial layers of the uterus as well as surrounding submucosal uterine 
glands. Multifocal small erosions and ulcerations of uterine mucosa with numerous 
neutrophils were also seen. 
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Mammary tissue from heifer #9 had alveoli containing moderate numbers of 
intraluminal neutrophils. Low numbers of lymphocytes were seen within the interstitium 
surrounding such alveoli. Supramammary lymph node changes in heifer #9 were consistent 
with those observed in cattle examined at PIW 8. 
Lung from the calf from heifer #9 had very mild multifocal interstitial thickening due 
to infiltrates of moderate numbers of macrophages and neutrophils. These areas were often 
found but not limited to peribronchiolar regions. Increased numbers of cells immimoreactive 
for CD68 were seen within the interstitium. Bronchi and bronchioles were normal with no 
intralimiinal or intraepithelial inflammation. 
Placentomes from noninfected, normal cows did not contain areas of necrosis or 
inflammation. In some sections, small areas of hemorrhage were present within the arcade 
zone. Foci of hemorrhage were not associated with necrosis of ttophoblastic epithelial cells 
or with infiltrates of inflammatory cells. 
Discussion-
This study shows that SRB51 has a tropism for the bovine placental trophoblast and 
induces placentitis which can result in premature birth. Abortion is defined as the premature 
expulsion from the uterus of the products of conception, of the embryo, or of a nonviable 
fetus.Although the calf from heifer #9 was premature and weak, the judgement of potential 
viability is subjective. To avoid confusion we have classified this delivery as a premature, 
weak calf and not an abortion. The infravenous inoculation of heifers in the sixth month of 
gestation represents a stringent test of virulence for any brucellosis vaccine candidate. It is 
unlikely that SRB51 would be given infravenously in field situations. However, despite this 
stringent test, lack of abortion shows that SRB51 is less virulent than other brucellosis 
vaccine strains, including SI9, when administered intravenously."^"^^'^ This decreased 
virulence in pregnant cattie contributes to the attractiveness of SRB51 as a vaccine for the 
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prevention of bovine brucellosis. Moreover, lack of antibodies which are detected by 
brucellosis surveillence tests, e.g. standard tube test, allows differentiation of SRB51-
vaccinated animals from naturally infected animals.'^^ Such differentiation is not possible 
following S19 vaccination. 
SRB51 - induced placental and uterine lesions in our cattle are similar to those 
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reported in cattle and other species infected with virulent B. abortus, and are consistent 
with the role of the trophoblast epithelium as the primary site of infection.^'^^ Placental 
inflammation and tropohoblast epithelial cell necrosis could allow passage of bacteria into 
the allantoic sac. Such a mechanism could explain the presence of SRJB51 in allantoic fluid 
of 40% of our heifers while the amniotic fluid was infected in only 10%. The amniotic 
membrane is not in intimate association with maternal tissues making extension of infection 
from the trophoblast layer less likely. The disseminated infection of many of the fetuses as 
well as the chorioallantoic vascuUtis suggest that hematogenous spread of infection also 
plays a role in fetal infection. 
T-lymphocytes of the CD4 type are known to be important in infections with 
intracellular bacteria." The activation of CD4+ T-cells and resultant secretion of IFN-y have 
been shown to be important in the protection of mice infected with other intracellular 
pathogens such as Listeria monocytogenes and Mycobacteria spp.'^ The presence of 
numerous CD4+ T-cells in the endometritis seen in the present study is consistent with a role 
for CD4+ T-cells in the response to SRB51. Although IFN-y levels were not measured in our 
cattle, IFN-y has been shown to be important in the control of intracellular growth of SRB51 
18 43 in murine macrophages as well as the infection of murine spleens with S2308. 
y/S T-cells do not appear to play a major role in SRB51-induced endometritis. The 
rare identification of y/6-T-cells in our study differs from the proposed mechanism of y/5-T-
cells in protection against intracellular pathogens in other species.^ In mice, y/5 T-cells 
colonize various tissues, including lung, tongue, skin, intestine, uterus, vagina and placenta.^ 
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In M. tuberculosis-m£ec\.Q& mice deficient in y/5 T-cell receptors, pulmonary infection is 
disseminated and not confined in granulomata as it is in genetically normal control mice or 
mice deficient in only the a/p T-cell receptor. This suggests a role for y/S T-cell in the 
containment of M. tuberculosis infection. A similar protective role has been seen in mice 
''S infected with L. monocytogenes.' 
Extrapolation of results regarding lymphocyte subsets in other species to cattle may 
not be appropriate. In contrast to mice, y/5 T-cells comprise a significantly higher proportion 
of peripheral blood mononuclear cells in ruminants.Although the precise role and 
significance of y/5 T-cells in ruminants is not clear, one study has shown that numbers of y/6 
T-cells are not altered in draining lymph nodes following subcutaneous inoculation of 
SRB51 It may be possible that y/5 T-cells are not major effector cells in SRB51-induced 
inflammation; however, in the present study, the lack of periodic analysis of y/5 T-cell 
involvement over the course of infection does not rule out the early involvement and/or 
possible destruction of y/5 T-cells in SRB51-induced endometritis. 
The incidence of fetal lung lesions in 5n/ce//a-infected, aborted fetuses or premature 
weak calves is highly variable, and is characterized as bronchitis or bronchopneumonia with 
predominantly mononuclear infiltrates."°'''° Interstitial lesions similar to those seen here have 
been reported.''^ 
Persistence of SRB51 infection to the termination of our study at 14 weeks differs 
from previous studies with SRB51 in which SRB51 was cleared by 6-weeks after inoculation 
Q 
in subcutaneously inoculated heifers Prolonged persistence may be due to differences in 
inoculation route, dosage or pregnancy status. Route of inoculation has been shown to 
influence the outcome of infection."^ Subcutaneous inoculation with B. abortus strain 45 is 
inocuous while intravenous inoculation results in abortion.^"* Additionally, our inoculum 
10 9 
dose, 10 CPU, is slightly higher than the dose of 5 to 7 x 10 used in previous vaccination 
g 
studies. The pregnancy status of cattle at inoculation also plays an important role in the 
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development of infection as other Brucella abortus strains have been shown to have a 
tropism for the placental trophoblast.^"^' 
In contrast to the persistence in tissue, lack of persistence of SRB5I in blood samples 
in the current study is possibly due to increased phagocytosis and killing of rough strains as 
compared to smooth strains.Previous studies have isolated virulent smooth B. abortus 
from pregnant cows 52 - 62 days following intravenous inoculation.'^ SRB51 is more 
sensitive to the bactericidal effects of complement when compared to smooth strains.'" 
10,13 
These differences have been attributed to the lack of 0-side chain on SRB51. 
Weak or negative serologic responses to SRB51 by perinatal calves are consistent 
with previous findings in SRB51 vaccinated cattle.^ Morphologic evidence for this lack of 
response was evident in the present study as splenic germinal center formation was absent in 
all calves examined. Although anatomically the components of the fetal immune system may 
be present by day 175 of gestation/^ fetal changes responsible for immunologic maturity 
may not occur at the same time for all antigens.^' In a previous study, bovine fetuses 
experimentally infected with the smooth S2308 had increased levels of both IgM and IgG.'"* 
Being a rough derivative of S2308, it is possible that the rough nature of SRB51 may 
contribute to decreased immunogenicity in fetuses. 
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CHAPTER 3. SAFETY AND IMMUNOGENICITY OF THE VACCINE BRUCELLA 
ABORTUS STRAIN RB51 IN PREGNANT CATTLE 
A paper submitted to the American Journal of Veterinary Research 
(In press, accepted for publication 11/19/96) 
Mitchell V. Palmer DVM, Steven C. Olsen DVM, PhD, and Norman F. Cheville DVM, PhD 
Objective- Determine the safety and immunogenicity of Brucella abortus strain RB51 as a 
vaccine in pregnant cattle. 
Animals- Twelve Polled Hereford heifers obtained from a brucellosis-free herd and bred on 
site at 16 months of age with a brucellosis-free bull. 
Procedure - Pregnant heifers were vaccinated SC at 6 months' gestation with 10^ CFU 
Brucella abortus strain RB51 (n=5), 3x10^ CFU B abortus strain 19 (n=5), or sterile 
pyrogen free saline (n=2). Periodic blood samples were collected for serology and 
lymphocyte blastogenesis assays. At full gestation, heifers were euthanatized and maternal 
and calf tissues and fluid specimens were collected for bacteriologic culture, histologic 
analysis, and lymphocyte blastogenesis using various antigenic stimuli (y-irradiated strain 
RB51, y-irradiated strain 19, strain RB51 LPS or strain 2308 LPS). 
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Results- None of the strain RB51- or strain 19-vaccinates aborted or had gross or 
microscopic lesions at necropsy consistent with brucellosis. Two of five strain RB51-
vaccinates had strain RB51 in superficial cervical lymph nodes draining the site of 
vaccination. No other maternal or calf tissues contained strain RB51. Maternal PBMC from 
strain RB51-vaccinates and strain 19-vaccinates showed proliferative responses to both y-
irradiated strain RB51 and strain 19 which were greater than nonvaccinated controls. In 
contrast, maternal superficial cervical lymph node cells from strain 19-vaccinates, but not 
strain RB51-vaccinates, demonstrated proliferative responses to y-irradiated strain RB51 or 
strain 19 bacteria that were greater than that seen in nonvaccinated controls. PBMC from 
calves of strain RB51- and strain 19-vaccinates showed proliferative responses greater than 
nonvaccinated controls to irradiated strain RB51, strain RB51 LPS, and strain 2308 LPS. 
None of the heifers vaccinated with strain RB51 developed antibodies detected by the 
standard tube agglutination test, but all developed antibodies to strain RJB51 that reacted in a 
dot ELISA test using irradiated strain RB51 as antigen. 
Conclusions- Pregnant cattle can be safely vaccinated with 10 CPU strain RB51 without 
subsequent abortion or placentitis. Furthermore, strain RB51 is immunogenic in pregnant 
cattle and induces humoral and cell mediated responses. 
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Clinical relevance- Safety and immunogenicity of B abortus strain RB51 in pregnant cattle, 
with the absence of antibodies that interfere with serologic diagnosis of field infections, make 
it a desirable vaccine to be used in situations in which whole herd vaccination is necessary. 
Brucellosis is an economically important abortifacient disease of cattle caused by the 
bacterium Brucella abortus. Vaccination of heifers with the vaccine Brucella abortus strain 
19 (SI 9) has been integral to the decreased prevalence of bovine brucellosis in the United 
States since the inception of the brucellosis eradication effort in 1940. Although effective as 
a vaccine, S19 has several limitations including the ability to induce abortion in pregnant 
cattle.' Another limitation which continues to interfere with brucellosis eradication efforts is 
the production of antibodies following S19 vaccination which are indistinguishable on 
brucellosis siurveillance tests from those produced by natural infection with field strains." 
Limitations of the current brucellosis serologic tests makes the distinction of naturally 
infected animals from S19-vaccinates problematic. 
Brucella abortus strain RB51 (SRB51), a rough mutant of the virulent Brucella 
abortus strain 2308,^ has recently been approved in the United States for use as a brucellosis 
vaccine for calves. SRB51 has been shown to be protective in cattle and does not produce 
antibodies which cross react on serologic surveillance tests,'*'^ enabling the distinction 
between vaccinated and naturally infected animals. The possibility of placental and fetal 
infection with SRJB51 was established by the experimental FV inoculation of pregnant cattle 
with very high numbers of SRB51, however, abortion was not observed.^ The question of 
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placental tropism when SRB51 is given in lower numbers and by the recommended route, 
i.e., SC inoculation, has not been established. 
This study was designed to determine the safety and immunogenicity of SRB51 in 
pregnant cattle when the vaccine is administered by the recommended route, using a dosage 
which has been used in previous field investigations.^ Both humoral and cell mediated 
immune responses were analyzed as a measure of immune responsiveness. 
Materials and Methods 
Polled Hereford heifers used in the experiment were obtained firom a nonvaccinated, 
brucellosis-free herd. Heifers were 16 months old at breeding. Prior to shipment and again 
prior to vaccination, all cattle were serologically negative for brucellosis by the standard tube 
g 
agglutination test (STAT). Upon arrival, and throughout the experiment, cattle were kept on 
pasture. Breeding was by natural service using a Polled Hereford bull which was 
serologically negative for brucellosis as determined by STAT. 
At six mondis' gestation, animals were randomly divided into 3 groups and injected 
with 9.4 X 10^ CFU SRB51 (n=5), 3x10^ CPU S19 (n=5), or 2 ml sterile pyrogen free 
saline, (n=2). All animals were injected SC in the right prescapular region. The dosage of 
SRB51 used previously in adult vaccination studies is 10^ CFU,' while the recommended 
adult dose of strain 19 is 3-10 x 10^ CFU. ^ 
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Body temperatures were recorded daily for the first four days after vaccination and 
animals were observed twice daily for the duration of the experiment for adverse reactions or 
clinical signs. 
Necropsy- All cattle were euthanatized at full gestation by IV administration of sodium 
pentobarbital/ Samples of maternal uterus, placentome, intercotyledonary placenta, 
mammary gland, supramammary lymph node, liver, spleen, and calf liver, spleen, lung and 
bronchial lymph node were obtained for bacteriologic culture and histologic analysis. 
Immunohistochemical staining for SRB51 antigen was done on tissues from SRB51-infected 
heifers and calves. Maternal blood, milk, vaginal swab specimens, allantoic and amniotic 
fluids and calf blood, cerebrospinal fluid, abomasal contents and rectal swab specimens, were 
also collected for bacterial culture 
Histologic and Immunocytochemical analyses- Tissue specimens were placed in neutral 
buffered 10% formalin. Tissues were processed by routine paraffin embedment techniques, 
cut 4 to 6 |im thick and stained with H&E. Unstained sections were used for 
immunohistochemical staining of SRB51 antigen using an avidin-biotin-alkaline phosphatase 
complex staining technique as described and a commercially available kit.'' Polyclonal 
anti-SRB51 antibodies were prepared by hyperimmunization of rabbits with whole cell, y-
irradiated SRB51. 
'Sleepaway, Fort Dodge Co., Fort Dodge, lA. 
''Histomark, Kirkegaard and Perry Laboratories, Inc., Gaithersburg, MD. 
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Anti-SRB51 antiserum was used at a dilution of 1:1000 based on previous work using 
sections of SRB51-infected murine spleens or bovine lymph nodes.'' Control 
slides were stained with serum from nonimmunized, clinically normal rabbits. Sections of 
SRB51-infected BALB/c mouse spleen and liver were used as positive control slides. 
Bacteriologic analysis - B abortus strain RB51 and strain 19 were used in this study. 
SRB51 vaccine was obtained from a commercial vaccine supplier*^ and diluted appropriately 
using the supplied diluent. Strain 19 vaccine was obtained and prepared as directed for the 
vaccination of adult animals. 
Tissue and fluid samples to be tested for SRB51 or S19 were processed as described 
using tryptose agar (TSA) and TSA with 5% bovine serum, cyclohexamide (30 |ag/ml), 
bacitracin (7.5 U/ml), polymyxin B sulfate (1.8 U/ml) and ethylviolet (1:300,000).'^ 
g 
Brucella colonies were identified by colony morphology and growth characteristics. 
Collection and handling of blood for culture - At time periods corresponding to 
postvaccination day (PVD) 1-4 and postvaccination week (PVW) 1-12, 100 ml of blood was 
collected aseptically for culture and processed as described.^ Calf blood was processed 
similarly at necropsy. 
"^Colorado Serum Co., Denver, CO. 
'' National Veterinary Services Laboratory, Ames, lA. 
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Serologic analysis - Blood was collected by venipuncture from each heifer prior to 
vaccination and at PVW 1-12, and from calves at necropsy. Maternal and calf blood was 
collected into sterile 10-ml tubes, allowed to clot for 6-24 hrs at 4°C, and centrifuged. Serum 
was divided into 2 ml aliquots, frozen, and stored at -70''C. 
The STAT, and a previously described dot ELISA for antibodies to SRB51 were used to 
evaluate antibody responses/^ 
Lymphocyte proliferation assay - Assays were done on peripheral blood mononuclear 
cells (PBMC) collected prior to vaccination (PVD 0), on PVW 2,4, 6, 8, 10 and 12, and from 
calves at necropsy. Fifty milliliters of blood was collected in 5 ml acid citrate buffer as 
anticoagulant. Following centrifugation, plasma was decanted and cells were placed on a 
Ficoll gradient^ (s.g. 1.083 g/dl) for separation. PBMC were processed and resuspended to a 
7 14 5 
concentration of 10 viable cells/ml in RPMI 1640 medium. A 50 |j.l aliquot (5x10 cells) 
of the PBMC suspension was added in duplicate to separate flat-bottom wells of a 96-well 
microtiter plate containing 100 jj.1 of various concentrations of y-irradiated B abortus SRB51 
(10^ to 10^ bacteria/well), S19 (10^ to 10^ bacteria/well), SRB51 LPS (20 to .02 |ig/well), or 
S2308 LPS (2.5 to .025 |ig/well) in a solution of RPMI 1640 medium containing L-
glutamine, 25mM Hepes, 10% fetal bovine serum, lOOU/ml penicillin, lOOfxg/ml 
streptomycin and 5 x 10'^ M 2-mercaptoethanol. Lymphocytes were collected for 
blastogenesis assays at necropsy from maternal sites (superficial cervical lymph nodes, 
supramammary lymph nodes), and calf sites (parotid lymph nodes, mesenteric lymph nodes 
and spleen) and prepared as described.'^ A 50 |il aliquot (5 x 10^ cells) of lymph node (LN) 
cell suspension was added in duplicate to separate flat-bottomed wells of a 96-well 
microtiter plate as described.'^ Lymph node and PBMC cell cultures were incubated for 7 
® Histopaque 1083, Sigma Daignostics, St. Louis, MO. 
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days at 37°C in 5% CO2, pulsed with l.O fiCi per well of [^H]-thynudine for 18 hours, 
harvested on to glass filters and counted for radioactivity in a liquid scintillation counter. 
Cell proliferation results were expressed as the mean counts per minute (CPM) ± the 
standard error of the mean. 
Statistical analysis - Differences in responses between treatments were compared by a 
repeated measures, general linear models procedure using the SAS system.^ For statistical 
comparisons, [^H] thymidine incorporation and antibody titers were also evaluated as the 
logarithm of the CPM or logarithm of the antibody titer. Means for individual treatments 
were separated by use of a least significant difference procedure (P < 0.05). 
Results 
Clinical Signs - All animals remained clinically normal throughout the experiment. Febrile 
responses were not detected in any animal during the first 4 days after vaccination. 
Abortions or premature births did not occur. Evidence of arthritis or anaphylactic shock was 
not seen in animals in either vaccine group. 
Postmortem examination - Gross or microscopic lesions were not seen in cattle vaccinated 
with either SRB51 or SI9. Similarly, lesions were not seen in calves fi-om vaccinated cattle 
in either group. Immunohistochemical staining of tissue sections fi:om SRB51-vaccinates 
revealed no SRB51 antigen. 
Bacteriology results - Strain RB51 was isolated from superficial cervical lymph nodes on 
the side of initial vaccination in 2/5 cases. No other maternal tissues, including placentomes 
^ SAS Institute Inc., Cary, NC. 
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or intercotyledonary placenta contained SRB51 or SI9. Similarly, no maternal blood 
samples taken at any time point from either vaccine group contained SRB51 or SI9. No 
tissues or fluid specimens examined from calves from either group contained SRB51 or SI9. 
Serology - All SRB51-vaccinates remained serologically negative by STAT throughout the 
experiment (Fig 1). SI9 vaccinates showed peak STAT titers at PVD 14 which steadily 
declined to the termination of the smdy. Both SRB51- and S19-vaccinates showed dot 
ELISA titers to y-irradiated SRB51 (Fig 2). However, peak dot ELISA titers, were greater 
(P<0.05) in SRB51-vaccinates at PVD 42, 56 and 70. Nonvaccinated control heifers and 
calves from all groups showed no titers by either STAT or dot ELISA (data not shown). 
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Figvire 1- Serum antibody responses of heifers vaccinated during pregnancy with Brucella 
abortus SRB5I or S19 as measured by the standard tube agglutination test. Results are 
expressed as mean titer ±S.E. 
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Figure 2- Serum antibody responses of heifers vaccinated during pregnancy with Brucella 
abortus SRB51 or S19 as measured by a dot ELISA test for antibodies to SRB51. Results 
are expressed as mean titer ± S.E. Titers of SRB51-vaccinates at 6, 8 and 10 weeks after 
vacciation are significantly (P<0.05) greater than titers of SI 9-vaccinates. 
Maternal cell mediated response - Blastogenesis assays of maternal PBMC revealed a 
greater (P<0.05) proliferative response in both vaccine groups than in nonvaccinated controls 
when PBMC were incubated with either y-irradiated-SRB51 or S19 (Fig 3). Although 
proliferative responses to y-irradiated S19 were greater (P<0.05) in S19-vaccinates than in 
SRB51-vaccinates on PVD 28 and 70, proliferative responses to y-irradiated SRB51 were 
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significantly different between S19 and SRB51-vaccinates at PVD 56 only. Similarly^ 
differences were not seen (P>0.05) between vaccinated and nonvaccinated cattle when 
maternal PBMC were incubated with LPS derived from SRB51 or S2308 (data not shown). 
Response of maternal superficial cervical node cells obtained at necropsy from 
SRB51-vaccinates did not differ (P>0.05) from that seen in nonvaccinated controls to any of 
the antigens tested (Fig 4). However, superficial cervical lymph node cells from S19-
vaccinates showed greater (P<0.05) proliferative responses to y-irradiated SRB51, and y-
uxadiated S19 than that seen in nonvaccinated controls and SRB51-vaccinates. Cells from 
maternal supramammary lymph node of SRB51- or SI9-vaccinates did not show proliferative 
responses that were significantly different (P>0.05) from controls (data not shown). 
Calf cell mediated response - PBMC from calves of SRB51-vaccinates showed greater 
(P<0.05) proliferation than nonvaccinated controls in response to y-irradiated SRB51, RB51 
LPS and 2308 LPS ( Fig 5). PBMC from calves of S19-vaccinates also showed significantly 
higher (P<0.05) responses to y-irradiated SRB51, SRB51 LPS and S2308 LPS, as well as y-
irradiated S19 than did nonvaccinated controls (Fig 5). PBMC from calves of S19-vaccinates 
had greater responses (P<0.05) to y-irradiated SRB51, y-irradiated SI9, and SRB51 LPS than 
did PBMC from calves of cows vaccinated with SRB51. Cells from calf parotid lymph node, 
calf mesenteric lymph node and calf spleen of SRB51- or S 19-vaccinates did not show 
proliferative responses that were significantly different (P>0.05) from controls (data not 
shown). 
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Figure 3- Proliferation of PBMC from SRB51-vaccinated, Sl9-vaccinated, or saline-
inoculated pregnant heifers to A)10^y-irradiated SRB51 or B) lO^y-irradiated S19. PBMC 
were incubated for 7 days with killed bacteria prior to being pulsed for 18 hrs. with [^H]-
thymidine. Results are presented as mean ± S.E. cpm of duplicate cultures; PVD = 
postvaccination day. 
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Control srb51 Control 
Figure 4- Proliferation of maternal superficial cervical lymph node cells from SRB51-
vaccinated, SI9- vaccinated, or saline-inoculated pregnant heifers to: A-10^ y-irradiated 
SRB51, B-10^ y-irradiated SI9, C- 2.5 |j.g SRB51 LPS, or D- 3.1 jig S2308 LPS. Lymph 
node cells were incubated for 7 days with antigen and then pulsed for 18 hrs. with [^H]-
thymidine. Results are expressed as mean ± S.E. cpm of duplicate cultures. Means with 
different superscripts differ significantly (P<0.05). 
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Figure 5- Proliferation of calf PBMC from SRB 51-vaccinated, SI 9- vaccinated, or saline-
inoculated pregnant heifers. See figure 4 for legend. 
84 
Discussion 
Results of this study support the use of SRB51 in pregnant cattle by showing that pregnant 
cattle can be safely vaccinated with SRB51 when inoculated SC using a dose of lO' CFU 
SRB51. Specifically, vaccination of pregnant cattle with SRB51 did not result in generalized 
infection of maternal or calf tissues but did induce cell mediated and humoral immune 
responses. However, small animal numbers decrease the likelihood of detecting rare vaccine-
induced abortions. Likewise, no S19-induced abortions were seen in the present study. 
Although S19-induced abortions do occur, a large study involving the SC vaccination or 
>10,000 pregnant catde with S19, showed abortions occur in <1%.' 
Lymphocyte blastogenesis results of maternal PBMC in this study indicate that 
pregnant cattle develop a cell mediated immune (CMI) response to SRB5I by PVD 28. 
Heifer calves have been shown to develop a CMI response to SRB51 and S2308 protein 
fractions 10-12 wks after vaccination vnth a slightly higher dose of SRB51.''' Blastogenic 
responses to S2308 and SRB51 proteins were similar even though SRB51 fractions do not 
contain the 0-side chain of LPS.'"* Our studies flirther confirm that the LPS of S2308 is not 
blastogenic for PBMC or superficial cervical lymph node cells from SRB51-vaccinated 
cattle. The blastogenic and humoral responses of S19-vaccinates to y-irradiated SRB51 was 
not unexpected as the outer membrane proteins of Brucella species have been shown to be 
remarkably similar.Results of this study are also similar to data obtained from another 
study in which S19-vaccinates developed humoral responses to irradiated SRB51.'^ These 
studies suggest that S19 and SRB51 share common epitopes to which immune responses are 
directed. 
The development of a CMI response in the PBMC of calves from SRB51- or SI 9-
vaccinates suggests exposure of the calf to vaccine antigens although SRB51 or S19 were not 
isolated from calf tissues or placental membranes. It cannot be excluded that fetal infection 
occurred following vaccination, with bacteria cleared by immune responses prior to 
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parturition. Fetal immune responses to Brucella antigens are possible as the anatomic 
18 
components of the fetal immime system are present by day 175 of gestation. Although 
pregnant heifers were vaccinated at 180 days of gestation, lack of CMI response by other calf 
lymphoid tissues and the lack of a calf humoral response suggest that the calf immune system 
may not be functionally mature in relation to response to Brucella antigens. 
A previous study using IV inoculation of pregnant cattle with SRB51 showed generalized 
fetal infection with SRB51 while only one of ten fetuses developed a humoral response.® 
Another previous study with bovine fetuses experimentally inoculated with S2308 showed 
increased levels of both IgG and IgM.'^ Differences in fetal response to S2308 and SRB51 
may be due to the lack of the 0-side chain of the lipopolysaccharide of SRB51 or to 
differences in the amount of antigen to which the fetus was exposed. 
The results of this study further indicate that route of vaccination and dosage have 
significant effects on the outcome of vaccination with SRB51. Intravenous inoculation of 
10'° CFU SRB51 to cattle at 6 months of gestation results in placentitis and fetal infection.® 
Conversely, lack of placentitis as well as absence of localization of SRB51 in other tissues, 
i.e. spleen, liver, etc., in the present study, suggest that systemic spread and colonization of 
SRB51 do not occur following SC vaccination with 10^ CFU SRB51. Route of inoculation 
has also been demonstrated to be critical with other brucellosis vaccines such as strain 45 or 
S19 which consistently cause abortion when administered IV but cause few or no abortions 
when administered SC.' 
Persistence of SRB51 in the present study in superficial cervical lymph nodes lymph 
nodes to 12 weeks after vaccination differs from previous findings.'^ In calves vaccinated 
SC with 10'° CFU SRB51 in the superficial cervical region, SRB51 was not isolated from 
lymph node biopsies beyond 6 weeks after vaccination.'^ Persistence in pregnant cattle may 
be related to age or pregnancy status at vaccination which may influence immune ftmction. 
Moreover, clearance of S19 from superficial cervical lymph nodes prior to the clearance of 
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SRB51 in the present study differs from that seen elsewhere.^^ However, the adult dose of 
t -J 
S19 used in the current study is roughly 30-fold less than that used previously. 
In agreement with previous findings, our SRB51-vaccinates did not develop antibody 
titers which were detected by STAT, thereby, facilitating the differentiation of SRB51-
vaccinates and naturally infected animals. Antibodies detected in the STAT are directed to 
the 0-side chain;" therefore, lack of STAT response in SRB51-vaccinates is thought to be 
due to the lack of 0-side chain on SRB51. ^ 
Lymphocyte blastogenesis and serologic reactions in the present study suggest an 
active immune response in pregnant animals without generalized infection of maternal 
reproductive or calf tissues. However, vaccination with SRB51 during pregnancy followed 
by challenge with a virulent strain of Brucella would be necessary to prove protective 
immune responses. Additionally, field tests with large numbers of pregnant cattle would also 
be needed to determine the true prevalence of SRB 51-induced abortion. In outbreak 
situations it has been the policy of the USDA to "whole herd vaccinate", vaccinating both 
female adults and calves. The current findings suggest that vaccination of pregnant cattle 
with SRB51 would provide a safe means to enhance resistance to Brucella infection. 
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CHAPTER 4. TUMOR NECROSIS FACTOR-a PRODUCTION IN PREGNANT 
CATTLE AFTER INTRAVENOUS OR SUBCUTANEOUS VACCINATION WITH 
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Abstract 
TNF-a is a key cytokine in inflammatory processes and mediates many of the clinical 
signs associated with endotoxemia due to gram negative bacterial infection. In order to 
determine the influence of brucellosis vaccination on TNF-a levels in pregnant cattle and the 
possible role of the placenta in TNF-a production, pregnant cattle were vaccinated FV with 
Brucella abortus strain RB51 (n=IO), SC with B. abortus strain RB5I (n=5), or SC with B. 
abortus strain 19 (n=5); controls received pyrogen free saline SC (n=2). Radioimmunoassays 
showed no elevations in TNF-a levels in serum or plasma from IV or SC vaccinated cattle 
that differed from controls (P>0.05). Similarly, TNF-a levels in amniotic and allantoic fluids 
from SC vaccinated cattle were not different from controls (P>0.05). Immunohistochemistry 
for TNF-a revealed increased immunoreactivity within trophoblastic epithelial cells in SC 
and rV vaccinated cattle. Immunoreactivity was most extensive in FV vaccinated cattle that 
developed vaccine induced placentitis. These studies indicate that SC vaccination for the 
prevention of brucellosis using recommended adult dosages does not result in elevations of 
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TNF-a in plasma, serum or placental fluids; however, vaccination of pregnant cattle does 
stimulate trophoblastic epithelial cells to express TNF-a even when placentitis is not 
histologically evident. 
1. Introduction 
Tumor necrosis factor-alpha (TNF-a) is a cytokine capable of altering immune and 
pathophysiologic responses. TNF-a is expressed in a variety of cell types; the most 
quantitatively important being the macrophage (Myers et al.,1995; Tracey et al.,1992). 
However, TNF-a is also produced by lymphocytes, mast cells, NK cells, neutrophils, B-cells, 
keratinoc5^es, microglial cells, smooth muscle cell and various tumor cells (Tracey et 
al.,1992). Various cell types also carry receptors for TNF-a (Le et al.,1987; Dayer et 
al.,1985). Consequently, the biological effects of TNF-a are numerous including: inhibition 
of lipoprotein lipase (Beutler et ai.,1985), pyretogenesis (Dinarello et al.,1986; Le et 
al.,1987), activation of neutrophils (Tsujimoto et al.,1986; Klebanoff et al.,1986), T-cell 
activation (Le et al.,1987), osteoclast activation (Bertolini et al.,1986), induction of 
endothelial cell procoagulant activity (Nawroth et al.,1986; Nawroth et al.,1986), mitogenic 
action on fibroblasts (Vilcek et al.,1986; Sugarman et al.,1985), induction of oncogenes, and 
induction of synthesis of acute phase proteins, prostaglandins (Dinarello et al.,1986; Dayer et 
al.,1985), collagenases (Dayer et al.,1985), granulocyte/macrophage-colony stimulating 
factor, IL-1 and TNF-a itself (Dinarello et al.,1986; Nawroth et al.,1986). 
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TNF-a levels are increased in response to a variety of stimuli, the most potent of 
which is endotoxin (Adams et al.,1990; Kenison et al.,1991)(Mannel et al.,1987), a 
lipopolysaccharide (LPS) in the cell wall of gram-negative bacteria. Endotoxin exposure 
results in numerous clinical signs, many of which are mediated through the production of 
TNF-a, including fever, anorexia, depression, hypotension, metabolic acidosis, transient 
hyperglycemia followed by hypoglycemia, gastrointestinal infarction, hemorrhage of the 
adrenal glands and pancreas, acute nephrosis, and interstitial pneimionitis (Mannel et 
al.,1987). Endotoxin exposure can also have significant effects on reproductive performance 
in cattle. Endotoxin has been shown to be luteolytic (Benyo et al.,1992), causing shortened 
interestrous intervals. Infusion of Salmonella typhimurium endotoxin in pregnant cows 
induces abortion within 4 to 10 days of infusion (Foley et al.,1993). Endotoxin infusion is 
followed by a rapid increase in maternal but not fetal TNF-a (Foley et al.,1993). 
Bovine brucellosis is an economically important abortifacient disease caused by the 
gram-negative bacterium Brucella abortus. Since 1940, an integral part of brucellosis 
prevention and eradication in the Untied States has been the vaccination of female calves 
with the live vaccine Brucella abortus strain 19 (S19). Although effective in decreasing the 
incidence of brucellosis, S19 has several disadvantages including the induction of abortion in 
some pregnant cattle (Nicoletti,1977). A new vaccine. Brucella abortus strain RB51 
(SRB51), has recently been approved in the United States as an official calfhood vaccine. A 
study in pregnant cattle showed that IV injection of SRB51 results in placental infection, 
placentitis and fetal infection; although, abortion was not seen (Palmer et al.,1996). Further 
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study showed SC vaccination of SRB5I did not result in placental infection, placentitis or 
fetal infection (Palmer et al., (in press)). 
This work was part of a vaccine safety study involving vaccination of pregnant cattle 
with SRB51. Clinical signs and pathology associated with reproduction of all groups have 
been reported elsewhere (Palmer et al.,1996; Palmer et al., (in press)). Briefly, one heifer 
vaccinated IV with SRB51 delivered a weak calf one month prior to the predicted calving 
date. No other premature births or abortions were noted in either the IV or SC vaccinated 
groups (Palmer et al.,1996; Palmer et al., (in press)). Eight of ten IV vaccinated cattle and 
0/10 SC vaccinated cattle developed placentitis which is described in detail elsewhere 
(Palmer et al.,1996; Palmer et al., (in press)). 
In the rV vaccinated group, 80% of cattle were febrile during the initial 24 to 48 hrs. 
after vaccination. All but two animals had normal body temperatures by 48 hrs. after 
vaccination and the remaining two were normal by 96 hrs. after vaccination. Cattle 
vaccinated SC with SRB51 or S19 showed no febrile response and did not differ from 
controls (Palmer et al.,1996; Palmer et al., (in press)). 
The current investigation was designed to determine the changes in TNF-a levels 
following vaccination with SRB51 or S19 as a measure of the toxicity of vaccine-associated 
LPS. Additionally, this investigation was designed to determine placental tissue for cellular 
sites of TNF-a production. 
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2. Materials and Methods-
Polled Hereford heifers used in this experiment were obtained from a nonvaccinated, 
brucellosis-free herd. Heifers were 16-27 months old at breeding. All cattle were 
serologically negative for brucellosis by standard tube agglutination (Alton et al.,1988). 
Upon arrival, and throughout the experiment, cattle were kept on pasture. Breeding was by 
natural service using a Polled Hereford bull which was serologically negative for brucellosis 
by standard tube agglutination. 
IV vaccination - At 6 months of gestation heifers were injected IV in the right jugular 
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vein with 10 CPU SRB51 suspended in 10 ml sterile saline (0.85% NaCl). At 
postvaccination week 8 (PVW), 5 heifers were randomly selected, euthanatized, and 
examined. The remaining catde were euthanatized at term (n=3) or following premature 
delivery (n=l). 
SC vaccination - At six months of gestation animals were randomly divided into 3 
groups and injected SC in the right prescapular region with 9.4 x 10® CPU SRB51, (n=5), 3 
x 10^ CPU SI9, (n=5), or 2 ml sterile pyrogen free saline, (n=2). The exact inocula dose 
reported above was determined retrospectively. The dosage of SRB51 used in adult 
vaccination studies is 10^ CPU (Palmer et al.,1995), while the recommended adult dosages of 
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S19 is 3-10 X 10^ CFU (United States Department of Agriculture et al.,1986). All animals 
were euthanatized at full term of pregnancy. 
In both rV and SC vaccinated cattle, body temperatures were recorded daily for the 
first 4 days following vaccination and animals were observed twice daily during the 
experiment for clinical signs of abortion, illness or other adverse reactions. 
Radioimmunoassay- Blood was collected 3 times prior to vaccination on days -7, -5 
and on the day of vaccination (day 0) and on postvaccination days (PVD) 1,2, 3,4, 7, 14, 21, 
28, 35,42,49, 56, 63. Blood was collected from the calves at necropsy. Amniotic and 
allantoic fluids were collected at necropsy from cattle vaccinated SC with SRB51 or SI9. 
Blood and placental fluids from SC vaccinated cattle were immediately placed in sterile tubes 
with EDTA, and centrifuged. Samples were filtered through a 0.22 ^im low protein binding 
filter and aliquotted in 2 ml vials and frozen at -70 C. Similarly, serum was collected from 
IV vaccinated cattle in sterile tubes without anticoagulant and allowed to clot for 4 to 6 hrs at 
4 C and centrifuged. Serum was removed, filtered as above, and aliquotted in 2 ml vials and 
frozen at -70 C. Plasma, serum, and placental fluid TNF-a levels were measured using a 
double-antibody radioimmimoassay (RIA) as described (Kenison et ai.,1990). 
Immunohistochemistry - Placental samples were placed in neutral 10% buffered 
formalin and processed by routine paraffin embedment techniques, cut 4-6 pim thick and left 
unstained. Staining for bovine TNF-a was done as described (Cirelli et al.,1995), with 
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modifications for deparaffinization of parafBn sections. An avidin-biotin-alkaline 
phosphatase complex staining technique was used as described (Pahner et al.,1996; Meador 
et al.,1986). Anti-bovine TNF-a antibody was prepared as described (Kenison et al.,1990), 
and used at a dilution of 1:500 - 1:1000. Blocking with 1% normal bovine serum for 15 min. 
prior to the application of the anti-TNF-a antibody was done to reduce background staining. 
Negative control slides included histologic sections stained with serum from clinically 
normal rabbits and slides stained with omission of the primary antibody. Macrophages 
within the individual tissue sections were highly immunoreactive for bovine TNF-a and were 
used as an intemal positive control. 
Statistical Analysis - Differences in TNF-a levels between groups were compared by 
a repeated measures, general linear models procedure using the SAS system (SAS Institute, 
Gary, NC). Differences between means were considered significant at a level of P<0.05. 
Prevaccination means on days -7, -5 and 0 were combined within groups to yield one 
prevaccination TNF-a value per group. 
3. Results -
Plasma TNF-a levels - Tumor necrosis factor-a levels in plasma of cattle vaccinated 
SC are shown (Figure 1). There were not significant differences between cattle vaccinated 
SC with SRB51 or S19 or given saline (P>0.05). However, in these three groups a 
significant rise (P<0.05) was seen in TNF-a levels over the course of the experiment which 
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peaked at 42-56 days after vaccination. Similarly, levels of TNF-a in serum of IV vaccinated 
cattle did not show significant elevations as compared to controls. Levels of TNF-a in 
amniotic fluid and allantoic fluid from SC vaccinated cattle were either undetectable or not 
elevated above that seen in control cattle (Figure 2). Calf plasma or serum did not contain 
significantly elevated TNF-a as compared to controls (Figure 3). 
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Figvire 1. Plasma TNF-a levels in cattle vaccinated SC with 10^ CFU SRB51 (n=5) or 3x10^ 
CFU S19 (n=5), IV v^ith 10'° CFU SRB51 (n=lO), or given saline (n=2). TNF-a levels were 
determined by radioimmunoassay and represent mean ± standard error. * Significantly 
greater in SC vaccinates than values at 0-14 days after vaccination (P<0.05). 
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Figure 2. TNF-a levels in amniotic (A), and allantoic (B) fluids from cattle vaccinated SC 
with lO' CFU SRB51 (n=5), 3x10® CFU S19 (n=5) or sterile saline (n=2). Values are 
expressed as mean ± standard error. 
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Immunohistochemistry Results - Placental sections from SRB51 IV vaccinated catde 
with placentitis showed staining of large regions of the trophoblast layer. Strongly 
immunoreactive trophoblastic epithelial cells contained diffuse cytoplasmic staining for 
TNF-a (Figure 4). In contrast, placental sections from SC vaccinated cattle (SI9 and 
SRB5I), which did not have placentitis, showed a punctate staining of trophoblastic 
epithelial cells with few cells having diffiise cytoplasmic staining (Figure 5). 
Immunoreactive pimctate foci within trophoblastic epithelial cells were multiple, round, 1-3 
(im in diameter and strongly immunoreactive for TNF-a. Staining was seen in multiple 
groups of adjacent cells bounded by groups of cells without TNF- a immunoreactivity. 
Macrophages which stained strongly for TNF-a were present within the chorion, 
endometrium, myometrium and within the submucosal region of the utems surrounding 
glands and vessels of both IV and SC vaccinated cattle (Figure 6). 
Saline-inoculated control catde showed immunoreactivity for TNF-a in low numbers 
of macrophages within the myometrium and subserosa. Macrophages between the outer 
longitudinal muscle layer and serosa, and macrophages adjacent to submucosal glands or 
vessels, stained strongly for TNF-a (Figiire 7). Low numbers of individual trophoblastic 
epithelial cells were also immunoreactive for bovine TNF-a with moderate difilise staining 
of the entire cytoplasm; however, the remainder of the trophoblast layer lacked 
immimoreactivity for TNF-a (Figure 8). 
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Figure 3. TNF-a levels in plasma of calves from dams vaccinated SC with 10^ CFU SRB51 
(n=5), 3x10^ CFU S19 (n=5), IV with 10'° CFU SRB51, or sterile saline (n=2). Values are 
expressed as mean ± standard error. 
4. Discussion 
These studies indicate that bovine trophoblastic epithelial cells can produce TNF-a 
and that TNF-a is produced by more trophoblastic epithelial cells during SRB51-induced 
placentitis than in controls or vaccinated cows without placentitis. The diffuse cytoplasmic 
TNF-a immunoreactivity seen in cases of placentitis may reflect increased expression of 
TNF-a. Intense punctate immunoreactivity for TNF-a seen in SC vaccinated cows also 
suggests increased expression over that seen in controls. 
Figure 4. Section of placenta from heifer vaccinated IV at 6 months gestation with 10^° CFU 
B. abortus strain RB51 and examined 8 weeks later. Note diffuse cytoplasmic 
immunoreactivity for TNF-a in trophoblastic epithelial cells. Alkaline phosphatase 
method. Gill's hematoxylin counterstain. Bar = 30 jim. 
Figure 5. Section of placenta from heifer at full term which was vaccinated SC at 6 months 
gestation with 10^ CFU B. abortus strain RB51. Note punctate cytoplasmic 
immunoreactivity for TNF-a in trophoblastic epithelial cells. Alkaline phosphatase 
method. Gill's hematoxylin counterstain. Bar = 30 jim. 
Figure 6. Section of placenta from heifer at full term which was vaccinated SC at 6 
months gestation with 10^ CFU B. abortus strain RB51. Note immunoreactivity 
for TNF-a in macrophages surrounding chorioallantoic arteriole. Alkaline 
phosphatase method. Gill's hematoxylin counterstain. Bar = 50 |im. 
Figure 7. Section of placenta from control heifer at full term which was injected SC with 
saline at 6 months gestation. Note lack of immunoreactivity for TNF-a in 
trophoblast layer. Alkaline phosphatase method. Gill's hematoxylin counterstain. 
Bar = 50 |im. 
Figure 8. Section of uterus from control heifer at full term which was injected SC with saline 
at 6 months gestation. Note immunoreactivity for TNF-a in macrophages in 
subserosa. Alkaline phosphatase method. Gill's hematoxylin counterstain. Bar = 
30 i^m. 
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However, Brucella were not recovered from SC vaccinated cattle and histologic signs of 
inflammation were not seen. In mice, endotoxin treatment results in the appearance of TNF-
a in secretory granules of granulocytes, monocytes and neutrophils in all tissues examined 
(Schmauder-Chock et al.,1994). The punctate TNF-a immunoreactivity in trophoblastic cells 
of SC vaccinated cattle may represent secretory granules containing TNF-a. 
The dose of endotoxin associated with our vaccinations may have been insufficient to 
induce changes seen in catde injected with endotoxin of other bacterial species. An 
experimental study in pregnant cattle with endotoxemia showed elevations in maternal 
plasma TNF-a following injection of Salmonella endotoxin; however, fetal plasma and 
amniotic and allantoic fluid TNF-a levels were not elevated above controls (Foley et 
al.,1993). The endotoxin of Brucella has been shown to be 10,000 fold less potent than that 
of Escherichia coli in eliciting fever in rabbits (Goldstein et al.,1992), and 1,000 fold less 
potent than Salmonella endotoxin in eliciting lysozyme release in neutrophils (Rasool et 
al.,1992). It should be noted that radioimmunoassay measures TNF-a regardless of 
bioactivity. Factors which inhibit TNF-a bioactivity, such as soluble TNF-a receptors, may 
interfere with bioactivity but not immunoreactivity of secreted TNF-a (Myers et al.,1995). 
It may be possible tliat SC vaccination induced changes within the placenta which 
were significant enough to increase TNF-a expression, but not significant enough to result in 
chemotaxis of inflammatory cells and disruption of cells or tissue. Immunoreactivity of 
TNF-a in bovine trophoblastic epithelial cells in cases of placentitis has not been 
demonstrated previously but is consistent with studies in women with preterm labor due to 
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infection. Elevated TNF-a has been measured in the amniotic fluid of women in preterm 
labor (Romero et al.,I989; Romero et al.,1989) (Laham et al.,1994) (Halgunset et al.,1994) 
with clinical as well as subclinical intrauterine infection. Furthermore, TNF-a production 
has been documented in human cytotrophoblasts and decidual cells (Chen et al.,1991; 
Stallmach et al.,l995). In response to TNF-a and/or EL-l, several cell types, including 
amnion and decidua synthesize prostaglandins (Dayer et al.,1985) (Riley et al.,1984)(Romero 
et al.,1989). Similarly, 10 |ag of recombinant human TNF-a causes abortion in mice 
(Parant,1987), while in a model of malaria-induced abortion, as little as 1.5 ^g will induce 
abortion in mice infected with Plasmodium vinckei (Clark et al.,1988). Therefore, it is 
hypothesized that bacterial products, such as LPS, stimulate maternal and/or fetal cells to 
produce cytokines, such as TNF-a, which in turn increase prostaglandin synthesis by 
intrauterine tissues resulting in the onset of labor (Romero et al.,1989). In cultured bovine 
luteal cells, TNF-a induces a dose dependent increase in luteal PGF2a and has an inhibitory 
effect on lutenizing hormone-induced progesterone production (Benyo et al.,l992). Both 
increased PGF2a and decreased progesterone levels are changes consistent with the onset of 
parturition in cattle. 
The reason is unknown for the increase in plasma TNF-a seen in SC vaccinated and 
control cattle which occurred 42-56 days after vaccination. This time period corresponds to 
approximately 7.5 to 8 months' gestation. Mononuclear cells from periparturient cattle have 
been shown to produce significantly more TNF-a than cows in mid to late lactation (Sordillo 
et al.,1995). However, all cattle in our study were housed together during the experiment; 
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therefore, the possibility of subclinical disease affecting all cattle which resulted in elevations 
of plasma TNF-a cannot be ruled out. 
Reasons for lack of postvaccination fever in our SC vaccinated cattle may include 
vaccine dose and age at vaccination. A previous report with S19 vaccination described fever 
and anorexia of 3-5 days duration in dairy and beef calves (Dale et al., 1957). However, the 
animals used were calves and the dose of S19 vaccine was unspecified. 
This study shows that SC vaccination vidth SRB51 or S19 and FV vaccination with 
SRB51 results in increased TNF-a immunoreactivity in histologic sections of placenta with 
and without placentitis. Although neither IV vaccination with SRB51 nor SC vaccination 
with SRB51 or S19 resulted in elevations in plasma TNF-a, the increased immunoreacitivity 
of TNF-a indicates the potential exists for a role in bovine abortion for TNF-a similar to that 
suspected in humans. 
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CHAPTER 5. GENERAL CONCLUSIONS 
General Discussion 
These studies show the vaccine Brucella abortus strain RB51 (SRB51) does have a 
tropism for the bovine placenta, similar to other strains of B. abortus\^^ however, even v^rith 
moderate placentitis and disseminated fetal infection, abortion was not seen. Placentitis 
could only be induced by higher than recommended dosages and IV inoculation. Subsequent 
studies showed that pregnant cattle can be safely vaccinated SC with lO' CPU SRB51 which 
induced both humoral and cell mediated immune responses without placentitis or fetal 
infection. 
When infected herds have been identified in the United States, action taken by the 
USD A may involve vaccination of the whole herd, including pregnant animals.The results 
presented here support the vaccination of pregnant cattle v^th SRB51. The protective value 
of SRB51 vaccination in pregnant cattle; however, can only be suggested from the data 
presented. Studies involving vaccination of pregnant cattie followed by challenge with the 
virulent strain 2308 would be required to determine true efficacy. 
These results further suggest that SRB5I induced abortion is a rare event in cattle. 
Vaccination of 10,000 head of pregnant cattle with S19 resulted in <1% abortion.® The 
number of cattle used in the present studies was small and the true prevalence of SRB51-
induced abortion will require the vaccination of large numbers of pregnant cattle. Field 
studies with SRB51 have vaccinated >800 pregnant cattle in various stages of gestation with 
1 SRB51-induced abortion.' 
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The disseminated infection of full tenn calves following IV vaccination without 
immune response by the calf suggests that calf infection may occur very late in gestation 
prior to calving or calves may not be functionally capable of moimting a response to SRB51. 
The presence of SRB51 infection in calves as early as 8 weeks after infection and 4 weeks 
prior to calving discounts the possibility of calf infection immediately prior to calving. In 
contrast, calves infected in utero with the virulent strain 2308 developed increased IgG and 
IgM.^ Differences between responses reported in S2308 infected calves and those seen here 
may be due to the rough nature of SRB51. Smooth Brucella spp. survive in macrophages 
which are important antigen presenting cells as well as effector cells of the immune 
response/ 
Humoral and cell mediated responses in pregnant cattle are similar to those seen in 
nonpregnant catde.'^' Lack of humoral responses detected by routine brucellosis 
surveillance tests, such as the card test or standard tube agglutination test, allow the 
differentiation of SRJB51 vaccinated animals from naturally infected animals.'^ Such 
differentiation is not possible with S19 vaccinated animals and should accelerate the 
brucellosis eradication effort. 
Adverse effects due to LPS induced TNF-a elevations may be of minimal concern 
under the parameters described in these studies. Lack of significant increases in circulating 
TNF-a levels following IV or SC vaccination with SRB51 and SC vaccination with S19 may 
be due to the decreased toxicity of Brucella LPS as compared to other gram negative 
pathogens."*' However, immunohistochemical detection of TNF-a in trophoblastic epithelial 
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cells of vaccinated cattle but not control catde suggests that vaccination did result in 
increased TNF-a expression by trophoblastic epithelial cells. The proposed role of placental 
TNF-a in women with premature labor,'" '' and abortion in mice,"^ is a key one. Our 
findings suggest that vaccination does have an effect on bovine placental TNF-a; however, 
this role remains poorly defined and deserves further investigation. 
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